BLASTP 2.2.26 [Sep-21-2011]
Reference: Altschul, Stephen F., Thomas L. Madden, Alejandro A. Schaffer,
Jinghui Zhang, Zheng Zhang, Webb Miller, and David J. Lipman (1997),
"Gapped BLAST and PSI-BLAST: a new generation of protein database search
programs", Nucleic Acids Res. 25:3389-3402.
Reference for compositional score matrix adjustment: Altschul, Stephen F.,
John C. Wootton, E. Michael Gertz, Richa Agarwala, Aleksandr Morgulis,
Alejandro A. Schaffer, and Yi-Kuo Yu (2005) "Protein database searches
using compositionally adjusted substitution matrices", FEBS J. 272:5101-5109.
Query= psy13289
(106 letters)
Database: pdbaa
62,578 sequences; 14,973,337 total letters
Searching..................................................done
>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In
A Putative Auto-Inhibition State
Length = 340
Score = 67.0 bits (162), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 36/74 (48%), Positives = 43/74 (58%), Gaps = 2/74 (2%)
Query: 31 RRPGLSLQVSAVESPAVSI--PSNLXXXXXXXXXXXXFVVEADDLVKICDLGRGAYGIVE 88
R PGL + A E P S P +L F V+ADDL I +LGRGAYG+VE
Sbjct: 9 RNPGLKIPKEAFEQPQTSSTPPRDLDSKACISIGNQNFEVKADDLEPIMELGRGAYGVVE 68
Query: 89 KMRHVATGTMMAVK 102
KMRHV +G +MAVK
Sbjct: 69 KMRHVPSGQIMAVK 82
>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein
Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d)
Length = 290
Score = 55.5 bits (132), Expect = 8e-09, Method: Compositional matrix adjust.
Identities = 25/35 (71%), Positives = 30/35 (85%)
Query: 68 VEADDLVKICDLGRGAYGIVEKMRHVATGTMMAVK 102
V+ADDL I +LGRGAYG+VEKMRHV +G +MAVK
Sbjct: 4 VKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVK 38
>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory
Dimer
pdb|3ENM|B Chain B, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory
Dimer
pdb|3ENM|C Chain C, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory
Dimer
pdb|3ENM|D Chain D, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory
Dimer
Length = 316
Score = 52.4 bits (124), Expect = 6e-08, Method: Compositional matrix adjust.
Identities = 24/37 (64%), Positives = 29/37 (78%)
Query: 66 FVVEADDLVKICDLGRGAYGIVEKMRHVATGTMMAVK 102
F V+ADDL I +LGRGAYG+VEK RHV +G + AVK
Sbjct: 29 FEVKADDLEPIXELGRGAYGVVEKXRHVPSGQIXAVK 65
>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase
Domain Complexed With Amp-Pnp
pdb|3ALN|B Chain B, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase
Domain Complexed With Amp-Pnp
pdb|3ALN|C Chain C, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase
Domain Complexed With Amp-Pnp
pdb|3ALO|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase
Domain Ternary Complex With Amp-Pnp And P38 Peptide
pdb|3VUT|A Chain A, Crystal Structures Of Non-Phosphorylated Map2k4
pdb|3VUT|B Chain B, Crystal Structures Of Non-Phosphorylated Map2k4
Length = 327
Score = 40.0 bits (92), Expect = 4e-04, Method: Compositional matrix adjust.
Identities = 18/33 (54%), Positives = 24/33 (72%)
Query: 70 ADDLVKICDLGRGAYGIVEKMRHVATGTMMAVK 102
A+DL + ++GRGAYG V KM H +G +MAVK
Sbjct: 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVK 53
>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137
pdb|1VYW|C Chain C, Structure Of Cdk2CYCLIN A WITH PNU-292137
pdb|2C4G|A Chain A, Structure Of Cdk2-Cyclin A With Pha-533514
pdb|2C4G|C Chain C, Structure Of Cdk2-Cyclin A With Pha-533514
pdb|2BPM|A Chain A, Structure Of Cdk2-Cyclin A With Pha-630529
pdb|2BPM|C Chain C, Structure Of Cdk2-Cyclin A With Pha-630529
pdb|2BKZ|A Chain A, Structure Of Cdk2-Cyclin A With Pha-404611
pdb|2BKZ|C Chain C, Structure Of Cdk2-Cyclin A With Pha-404611
pdb|2WIH|A Chain A, Structure Of Cdk2-Cyclin A With Pha-848125
pdb|2WIH|C Chain C, Structure Of Cdk2-Cyclin A With Pha-848125
pdb|2WIP|A Chain A, Structure Of Cdk2-Cyclin A Complexed With 8-Anilino-1-
Methyl-4,5-Dihydro-1h-Pyrazolo[4,3-H] Quinazoline-3-
Carboxylic Acid
pdb|2WIP|C Chain C, Structure Of Cdk2-Cyclin A Complexed With 8-Anilino-1-
Methyl-4,5-Dihydro-1h-Pyrazolo[4,3-H] Quinazoline-3-
Carboxylic Acid
pdb|2WPA|A Chain A, Optimisation Of 6,6-Dimethyl Pyrrolo 3,4-C Pyrazoles:
Identification Of Pha-793887, A Potent Cdk Inhibitor
Suitable For Intravenous Dosing
pdb|2WPA|C Chain C, Optimisation Of 6,6-Dimethyl Pyrrolo 3,4-C Pyrazoles:
Identification Of Pha-793887, A Potent Cdk Inhibitor
Suitable For Intravenous Dosing
pdb|2WXV|A Chain A, Structure Of Cdk2-Cyclin A With A Pyrazolo(4,3-H)
Quinazoline-3-Carboxamide Inhibitor
pdb|2WXV|C Chain C, Structure Of Cdk2-Cyclin A With A Pyrazolo(4,3-H)
Quinazoline-3-Carboxamide Inhibitor
Length = 309
Score = 32.3 bits (72), Expect = 0.073, Method: Compositional matrix adjust.
Identities = 13/37 (35%), Positives = 25/37 (67%)
Query: 67 VVEADDLVKICDLGRGAYGIVEKMRHVATGTMMAVKE 103
+V+ ++ K+ +G G YG+V K R+ TG ++A+K+
Sbjct: 3 LVDMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKK 39
>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp
pdb|1S9I|B Chain B, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp
Length = 354
Score = 31.6 bits (70), Expect = 0.10, Method: Compositional matrix adjust.
Identities = 14/32 (43%), Positives = 21/32 (65%)
Query: 71 DDLVKICDLGRGAYGIVEKMRHVATGTMMAVK 102
DD +I +LG G G+V K++H +G +MA K
Sbjct: 16 DDFERISELGAGNGGVVTKVQHRPSGLIMARK 47
>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer
Length = 395
Score = 31.6 bits (70), Expect = 0.12, Method: Compositional matrix adjust.
Identities = 15/32 (46%), Positives = 20/32 (62%)
Query: 71 DDLVKICDLGRGAYGIVEKMRHVATGTMMAVK 102
DD KI +LG G G+V K+ H +G +MA K
Sbjct: 68 DDFEKISELGAGNGGVVFKVSHKPSGLVMARK 99
>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein
Kinase Kinase 7 Activated Mutant (S287d, T291d)
Length = 318
Score = 31.6 bits (70), Expect = 0.12, Method: Compositional matrix adjust.
Identities = 15/38 (39%), Positives = 23/38 (60%)
Query: 66 FVVEADDLVKICDLGRGAYGIVEKMRHVATGTMMAVKE 103
+ E +DL + ++G G G V KMR TG ++AVK+
Sbjct: 20 YQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQ 57
>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain
pdb|4AGU|B Chain B, Crystal Structure Of The Human Cdkl1 Kinase Domain
pdb|4AGU|C Chain C, Crystal Structure Of The Human Cdkl1 Kinase Domain
Length = 311
Score = 31.2 bits (69), Expect = 0.16, Method: Compositional matrix adjust.
Identities = 13/29 (44%), Positives = 21/29 (72%)
Query: 75 KICDLGRGAYGIVEKMRHVATGTMMAVKE 103
KI +G G+YG+V K R+ TG ++A+K+
Sbjct: 7 KIGKIGEGSYGVVFKCRNRDTGQIVAIKK 35
>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In
Complex With Ch4987655 And Mgamp-Pnp
pdb|3OS3|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In
Complex With Ch4858061 And Mgatp
Length = 307
Score = 31.2 bits (69), Expect = 0.16, Method: Compositional matrix adjust.
Identities = 15/32 (46%), Positives = 20/32 (62%)
Query: 71 DDLVKICDLGRGAYGIVEKMRHVATGTMMAVK 102
DD KI +LG G G+V K+ H +G +MA K
Sbjct: 6 DDFEKISELGAGNGGVVFKVSHKPSGLVMARK 37
>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek1) In A Ternary Complex With
Compound 1, Atp-Gs And Mg2p
pdb|3EQD|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek1) In A Binary Complex With Atp-Gs
And Mg2p
pdb|3EQF|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek1) In A Binary Complex With K252a
And Mg2p
pdb|3EQG|A Chain A, X-ray Structure Of The Human Mitogen-activated Protein
Kinase Kinase 1 (mek1) In A Ternary Complex With Pd, Adp
And Mg2p
pdb|3EQH|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek1) In A Ternary Complex With U0126,
Adp And Mg2p
pdb|3EQI|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek1) In A Binary Complex With Adp And
Mg2p
Length = 360
Score = 31.2 bits (69), Expect = 0.16, Method: Compositional matrix adjust.
Identities = 15/32 (46%), Positives = 20/32 (62%)
Query: 71 DDLVKICDLGRGAYGIVEKMRHVATGTMMAVK 102
DD KI +LG G G+V K+ H +G +MA K
Sbjct: 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARK 64
>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek1) In A Complex With Ligand And
Mgatp
pdb|3DY7|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek1) In A Complex With Ligand And
Mgatp
pdb|3E8N|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek1) Complexed With A Potent Inhibitor
Rdea119 And Mgatp
pdb|3V01|A Chain A, Discovery Of Novel Allosteric Mek Inhibitors Possessing
Classical And Non-Classical Bidentate Ser212
Interactions.
pdb|3V04|A Chain A, Discovery Of Novel Allosteric Mek Inhibitors Possessing
Classical And Non-Classical Bidentate Ser212
Interactions
Length = 341
Score = 30.8 bits (68), Expect = 0.17, Method: Compositional matrix adjust.
Identities = 15/32 (46%), Positives = 20/32 (62%)
Query: 71 DDLVKICDLGRGAYGIVEKMRHVATGTMMAVK 102
DD KI +LG G G+V K+ H +G +MA K
Sbjct: 6 DDFEKISELGAGNGGVVFKVSHKPSGLVMARK 37
>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek1) In A Complex With Ligand And
Mgatp
pdb|3EQB|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek1) In A Complex With Ligand And
Mgatp
Length = 333
Score = 30.8 bits (68), Expect = 0.18, Method: Compositional matrix adjust.
Identities = 15/32 (46%), Positives = 20/32 (62%)
Query: 71 DDLVKICDLGRGAYGIVEKMRHVATGTMMAVK 102
DD KI +LG G G+V K+ H +G +MA K
Sbjct: 6 DDFEKISELGAGNGGVVFKVSHKPSGLVMARK 37
>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based
Allosteric Inhibitor Xl518 (Gdc-0973), Or Related
Analogs.
pdb|4AN3|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based
Allosteric Inhibitor Xl518 (Gdc-0973), Or Related
Analogs.
pdb|4AN9|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based
Allosteric Inhibitor Xl518 (Gdc-0973), Or Related
Analogs.
pdb|4ANB|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based
Allosteric Inhibitor Xl518 (Gdc-0973), Or Related
Analogs
Length = 301
Score = 30.8 bits (68), Expect = 0.18, Method: Compositional matrix adjust.
Identities = 15/32 (46%), Positives = 20/32 (62%)
Query: 71 DDLVKICDLGRGAYGIVEKMRHVATGTMMAVK 102
DD KI +LG G G+V K+ H +G +MA K
Sbjct: 9 DDFEKISELGAGNGGVVFKVSHKPSGLVMARK 40
>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp
pdb|3PP1|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgatp
Length = 328
Score = 30.8 bits (68), Expect = 0.19, Method: Compositional matrix adjust.
Identities = 15/32 (46%), Positives = 20/32 (62%)
Query: 71 DDLVKICDLGRGAYGIVEKMRHVATGTMMAVK 102
DD KI +LG G G+V K+ H +G +MA K
Sbjct: 6 DDFEKISELGAGNGGVVFKVSHKPSGLVMARK 37
>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound
Length = 322
Score = 30.8 bits (68), Expect = 0.19, Method: Compositional matrix adjust.
Identities = 15/32 (46%), Positives = 20/32 (62%)
Query: 71 DDLVKICDLGRGAYGIVEKMRHVATGTMMAVK 102
DD KI +LG G G+V K+ H +G +MA K
Sbjct: 6 DDFEKISELGAGNGGVVFKVSHKPSGLVMARK 37
>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With
Ucb1353770 And Amppnp
pdb|3SLS|B Chain B, Crystal Structure Of Human Mek-1 Kinase In Complex With
Ucb1353770 And Amppnp
Length = 304
Score = 30.8 bits (68), Expect = 0.21, Method: Compositional matrix adjust.
Identities = 15/32 (46%), Positives = 20/32 (62%)
Query: 71 DDLVKICDLGRGAYGIVEKMRHVATGTMMAVK 102
DD KI +LG G G+V K+ H +G +MA K
Sbjct: 25 DDFEKISELGAGNGGVVFKVSHKPSGLVMARK 56
>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine
pdb|2R3Q|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3M|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3I|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3N|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3O|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3P|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3K|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3J|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3L|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|1W8C|A Chain A, Co-crystal Structure Of
6-cyclohexylmethoxy-8-isopropyl-9h- Purin-2-ylamine And
Monomeric Cdk2
Length = 299
Score = 30.4 bits (67), Expect = 0.26, Method: Compositional matrix adjust.
Identities = 12/33 (36%), Positives = 22/33 (66%)
Query: 71 DDLVKICDLGRGAYGIVEKMRHVATGTMMAVKE 103
++ K+ +G G YG+V K R+ TG ++A+K+
Sbjct: 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKK 35
>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine
Length = 306
Score = 30.4 bits (67), Expect = 0.26, Method: Compositional matrix adjust.
Identities = 12/33 (36%), Positives = 22/33 (66%)
Query: 71 DDLVKICDLGRGAYGIVEKMRHVATGTMMAVKE 103
++ K+ +G G YG+V K R+ TG ++A+K+
Sbjct: 10 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKK 42
>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With Atp
pdb|4EOQ|C Chain C, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With Atp
Length = 301
Score = 30.4 bits (67), Expect = 0.27, Method: Compositional matrix adjust.
Identities = 12/33 (36%), Positives = 22/33 (66%)
Query: 71 DDLVKICDLGRGAYGIVEKMRHVATGTMMAVKE 103
++ K+ +G G YG+V K R+ TG ++A+K+
Sbjct: 6 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKK 38
>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
pdb|4BCQ|C Chain C, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
Length = 301
Score = 30.4 bits (67), Expect = 0.27, Method: Compositional matrix adjust.
Identities = 12/33 (36%), Positives = 22/33 (66%)
Query: 71 DDLVKICDLGRGAYGIVEKMRHVATGTMMAVKE 103
++ K+ +G G YG+V K R+ TG ++A+K+
Sbjct: 5 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKK 37
>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of
8-Anilino-1-Naphthalene Sulfonate
pdb|3PXQ|A Chain A, Cdk2 In Complex With 3 Molecules Of
8-Anilino-1-Naphthalene Sulfonate
pdb|3PXR|A Chain A, Apo Cdk2 Crystallized From Jeffamine
pdb|3PXY|A Chain A, Cdk2 In Complex With Inhibitor Jws648
pdb|3PXZ|A Chain A, Cdk2 Ternary Complex With Jws648 And Ans
pdb|3PY0|A Chain A, Cdk2 In Complex With Inhibitor Su9516
pdb|3PY1|A Chain A, Cdk2 Ternary Complex With Su9516 And Ans
pdb|3QL8|A Chain A, Cdk2 In Complex With Inhibitor Jws-6-260
pdb|3QQF|A Chain A, Cdk2 In Complex With Inhibitor L1
pdb|3QQG|A Chain A, Cdk2 In Complex With Inhibitor L2-5
pdb|3QQH|A Chain A, Cdk2 In Complex With Inhibitor L2-2
pdb|3QQJ|A Chain A, Cdk2 In Complex With Inhibitor L2
pdb|3QQL|A Chain A, Cdk2 In Complex With Inhibitor L3
pdb|3QRT|A Chain A, Cdk2 In Complex With Inhibitor Nsk-Mc2-55
pdb|3QRU|A Chain A, Cdk2 In Complex With Inhibitor Nsk-Mc1-12
pdb|3QWJ|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-142
pdb|3QWK|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-150
pdb|3QX2|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-190
pdb|3QX4|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-78
pdb|3QXO|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-84
pdb|3QZF|A Chain A, Cdk2 In Complex With Inhibitor Jws-6-52
pdb|3QZG|A Chain A, Cdk2 In Complex With Inhibitor Jws-6-76
pdb|3QZH|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-124
pdb|3QZI|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-126
pdb|3R1Q|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-102
pdb|3R1S|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-127
pdb|3R1Y|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-134
pdb|3R28|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-140
pdb|3R6X|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-158
pdb|3R71|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-162
pdb|3R73|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-164
pdb|3R7E|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-67
pdb|3R7I|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-74
pdb|3R7U|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-75
pdb|3R7V|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-9
pdb|3R7Y|A Chain A, Cdk2 In Complex With Inhibitor Kvr-2-88
pdb|3R83|A Chain A, Cdk2 In Complex With Inhibitor Kvr-2-92
pdb|3R8L|A Chain A, Cdk2 In Complex With Inhibitor L3-4
pdb|3R8M|A Chain A, Cdk2 In Complex With Inhibitor L3-3
pdb|3R8P|A Chain A, Cdk2 In Complex With Inhibitor Nsk-Mc1-6
pdb|3RAI|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-160
pdb|3RM6|A Chain A, Cdk2 In Complex With Inhibitor Kvr-2-80
pdb|3RM7|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-91
pdb|3ROY|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-154
pdb|3RPO|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-156
pdb|4EZ3|A Chain A, Cdk2 In Complex With Nsc 134199
pdb|4EZ7|A Chain A, Cdk2 In Complex With Staurosporine And 2 Molecules Of
8-Anilino-1- Naphthalene Sulfonic Acid
pdb|3QQK|A Chain A, Cdk2 In Complex With Inhibitor L4
pdb|3QTQ|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-137
pdb|3QTR|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-148
pdb|3QTS|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-12
pdb|3QTU|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-132
pdb|3QTW|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-13
pdb|3QTX|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-35
pdb|3QTZ|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-36
pdb|3QU0|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-38
pdb|3QXP|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-89
pdb|3R8U|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-132
pdb|3R8V|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-135
pdb|3R8Z|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-136
pdb|3R9D|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-135
pdb|3R9H|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-142
pdb|3R9N|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-21
pdb|3R9O|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-143
pdb|3RAH|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-22
pdb|3RAK|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-32
pdb|3RAL|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-34
pdb|3RJC|A Chain A, Cdk2 In Complex With Inhibitor L4-12
pdb|3RK5|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-72
pdb|3RK7|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-71
pdb|3RK9|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-74
pdb|3RKB|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-73
pdb|3RMF|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-33
pdb|3RNI|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-86
pdb|3RPR|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-49
pdb|3RPV|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-88
pdb|3RPY|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-40
pdb|3RZB|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-23
pdb|3S00|A Chain A, Cdk2 In Complex With Inhibitor L4-14
pdb|3S0O|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-138
pdb|3S1H|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-39
pdb|3SQQ|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-96
pdb|4GCJ|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-89
Length = 306
Score = 30.4 bits (67), Expect = 0.27, Method: Compositional matrix adjust.
Identities = 12/33 (36%), Positives = 22/33 (66%)
Query: 71 DDLVKICDLGRGAYGIVEKMRHVATGTMMAVKE 103
++ K+ +G G YG+V K R+ TG ++A+K+
Sbjct: 10 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKK 42
>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With Atp
pdb|4EOM|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With Atp
Length = 301
Score = 30.4 bits (67), Expect = 0.27, Method: Compositional matrix adjust.
Identities = 12/33 (36%), Positives = 22/33 (66%)
Query: 71 DDLVKICDLGRGAYGIVEKMRHVATGTMMAVKE 103
++ K+ +G G YG+V K R+ TG ++A+K+
Sbjct: 6 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKK 38
>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With Atp
pdb|4EOJ|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With Atp
Length = 302
Score = 30.4 bits (67), Expect = 0.27, Method: Compositional matrix adjust.
Identities = 12/33 (36%), Positives = 22/33 (66%)
Query: 71 DDLVKICDLGRGAYGIVEKMRHVATGTMMAVKE 103
++ K+ +G G YG+V K R+ TG ++A+K+
Sbjct: 6 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKK 38
>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E
pdb|4EOR|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Nu6102
pdb|4EOR|C Chain C, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Nu6102
Length = 298
Score = 30.4 bits (67), Expect = 0.27, Method: Compositional matrix adjust.
Identities = 12/33 (36%), Positives = 22/33 (66%)
Query: 71 DDLVKICDLGRGAYGIVEKMRHVATGTMMAVKE 103
++ K+ +G G YG+V K R+ TG ++A+K+
Sbjct: 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKK 35
>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With
The Inhibitor Indirubin-5-Sulphonate Bound
pdb|1E9H|C Chain C, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With
The Inhibitor Indirubin-5-Sulphonate Bound
pdb|1PKD|A Chain A, The Crystal Structure Of Ucn-01 In Complex With Phospho-
Cdk2CYCLIN A
pdb|1PKD|C Chain C, The Crystal Structure Of Ucn-01 In Complex With Phospho-
Cdk2CYCLIN A
Length = 297
Score = 30.4 bits (67), Expect = 0.27, Method: Compositional matrix adjust.
Identities = 12/33 (36%), Positives = 22/33 (66%)
Query: 71 DDLVKICDLGRGAYGIVEKMRHVATGTMMAVKE 103
++ K+ +G G YG+V K R+ TG ++A+K+
Sbjct: 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKK 35
>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Ro3306
pdb|4EOS|C Chain C, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Ro3306
Length = 300
Score = 30.4 bits (67), Expect = 0.28, Method: Compositional matrix adjust.
Identities = 12/33 (36%), Positives = 22/33 (66%)
Query: 71 DDLVKICDLGRGAYGIVEKMRHVATGTMMAVKE 103
++ K+ +G G YG+V K R+ TG ++A+K+
Sbjct: 5 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKK 37
>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
pdb|4EOP|C Chain C, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
Length = 300
Score = 30.4 bits (67), Expect = 0.28, Method: Compositional matrix adjust.
Identities = 12/33 (36%), Positives = 22/33 (66%)
Query: 71 DDLVKICDLGRGAYGIVEKMRHVATGTMMAVKE 103
++ K+ +G G YG+V K R+ TG ++A+K+
Sbjct: 5 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKK 37
>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2
Complexed With A Nucleoside Inhibitor
Length = 298
Score = 30.4 bits (67), Expect = 0.28, Method: Compositional matrix adjust.
Identities = 12/33 (36%), Positives = 22/33 (66%)
Query: 71 DDLVKICDLGRGAYGIVEKMRHVATGTMMAVKE 103
++ K+ +G G YG+V K R+ TG ++A+K+
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKK 34
>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A
pdb|1JST|C Chain C, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A
pdb|1JSU|A Chain A, P27(Kip1)CYCLIN ACDK2 COMPLEX
pdb|1FQ1|B Chain B, Crystal Structure Of Kinase Associated Phosphatase (Kap)
In Complex With Phospho-Cdk2
pdb|2C6T|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6T|C Chain C, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2CJM|A Chain A, Mechanism Of Cdk Inhibition By Active Site
Phosphorylation: Cdk2 Y15p T160p In Complex With Cyclin
A Structure
pdb|2CJM|C Chain C, Mechanism Of Cdk Inhibition By Active Site
Phosphorylation: Cdk2 Y15p T160p In Complex With Cyclin
A Structure
pdb|2UZB|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZB|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZD|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZD|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZE|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZE|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZL|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZL|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|4II5|A Chain A, Structure Of Pcdk2/cyclina Bound To Adp And 1 Magnesium
Ion
pdb|4II5|C Chain C, Structure Of Pcdk2/cyclina Bound To Adp And 1 Magnesium
Ion
Length = 298
Score = 30.4 bits (67), Expect = 0.28, Method: Compositional matrix adjust.
Identities = 12/33 (36%), Positives = 22/33 (66%)
Query: 71 DDLVKICDLGRGAYGIVEKMRHVATGTMMAVKE 103
++ K+ +G G YG+V K R+ TG ++A+K+
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKK 34
>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With The Inhibitor Ro3306
pdb|4EON|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With The Inhibitor Ro3306
Length = 300
Score = 30.4 bits (67), Expect = 0.28, Method: Compositional matrix adjust.
Identities = 12/33 (36%), Positives = 22/33 (66%)
Query: 71 DDLVKICDLGRGAYGIVEKMRHVATGTMMAVKE 103
++ K+ +G G YG+V K R+ TG ++A+K+
Sbjct: 4 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKK 36
>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of
Cyclin-dependent Kinase Inhibitors Identified Through
Structure-based Hybridisation
Length = 299
Score = 30.4 bits (67), Expect = 0.28, Method: Compositional matrix adjust.
Identities = 12/33 (36%), Positives = 22/33 (66%)
Query: 71 DDLVKICDLGRGAYGIVEKMRHVATGTMMAVKE 103
++ K+ +G G YG+V K R+ TG ++A+K+
Sbjct: 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKK 35
>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM
IONS
pdb|4I3Z|C Chain C, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM
IONS
Length = 296
Score = 30.4 bits (67), Expect = 0.28, Method: Compositional matrix adjust.
Identities = 12/33 (36%), Positives = 22/33 (66%)
Query: 71 DDLVKICDLGRGAYGIVEKMRHVATGTMMAVKE 103
++ K+ +G G YG+V K R+ TG ++A+K+
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKK 34
>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex
pdb|1QMZ|C Chain C, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex
pdb|1GY3|A Chain A, Pcdk2CYCLIN A IN COMPLEX WITH MGADP, NITRATE AND PEPTIDE
SUBSTRATE
pdb|1GY3|C Chain C, Pcdk2CYCLIN A IN COMPLEX WITH MGADP, NITRATE AND PEPTIDE
SUBSTRATE
pdb|1P5E|A Chain A, The Strucure Of Phospho-Cdk2CYCLIN A IN COMPLEX WITH THE
Inhibitor 4,5,6,7-Tetrabromobenzotriazole (Tbs)
pdb|1P5E|C Chain C, The Strucure Of Phospho-Cdk2CYCLIN A IN COMPLEX WITH THE
Inhibitor 4,5,6,7-Tetrabromobenzotriazole (Tbs)
pdb|2CCH|A Chain A, The Crystal Structure Of Cdk2 Cyclin A In Complex With A
Substrate Peptide Derived From Cdc Modified With A
Gamma- Linked Atp Analogue
pdb|2CCH|C Chain C, The Crystal Structure Of Cdk2 Cyclin A In Complex With A
Substrate Peptide Derived From Cdc Modified With A
Gamma- Linked Atp Analogue
pdb|2CCI|A Chain A, Crystal Structure Of Phospho-Cdk2 Cyclin A In Complex With
A Peptide Containing Both The Substrate And Recruitment
Sites Of Cdc6
pdb|2CCI|C Chain C, Crystal Structure Of Phospho-Cdk2 Cyclin A In Complex With
A Peptide Containing Both The Substrate And Recruitment
Sites Of Cdc6
pdb|2G9X|A Chain A, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
COMPLEX WITH THE Inhibitor Nu6271
pdb|2G9X|C Chain C, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
COMPLEX WITH THE Inhibitor Nu6271
pdb|3DDP|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Cr8
pdb|3DDP|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Cr8
pdb|3DDQ|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Roscovitine
pdb|3DDQ|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Roscovitine
pdb|3DOG|A Chain A, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
Complex With The Inhibitor N-&-N1
pdb|3DOG|C Chain C, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
Complex With The Inhibitor N-&-N1
Length = 299
Score = 30.4 bits (67), Expect = 0.28, Method: Compositional matrix adjust.
Identities = 12/33 (36%), Positives = 22/33 (66%)
Query: 71 DDLVKICDLGRGAYGIVEKMRHVATGTMMAVKE 103
++ K+ +G G YG+V K R+ TG ++A+K+
Sbjct: 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKK 35
>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site
pdb|3EZV|A Chain A, Cdk-2 With Indazole Inhibitor 9 Bound At Its Active Site
Length = 300
Score = 30.4 bits (67), Expect = 0.28, Method: Compositional matrix adjust.
Identities = 12/33 (36%), Positives = 22/33 (66%)
Query: 71 DDLVKICDLGRGAYGIVEKMRHVATGTMMAVKE 103
++ K+ +G G YG+V K R+ TG ++A+K+
Sbjct: 4 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKK 36
>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B
Length = 289
Score = 30.4 bits (67), Expect = 0.28, Method: Compositional matrix adjust.
Identities = 12/33 (36%), Positives = 22/33 (66%)
Query: 71 DDLVKICDLGRGAYGIVEKMRHVATGTMMAVKE 103
++ K+ +G G YG+V K R+ TG ++A+K+
Sbjct: 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKK 35
>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu2058
pdb|1H1P|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu2058
pdb|1H1Q|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6094
pdb|1H1Q|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6094
pdb|1H1R|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6086
pdb|1H1R|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6086
pdb|1H1S|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6102
pdb|1H1S|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6102
pdb|1H24|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH A 9 RESIDUE RECRUITMENT
Peptide From E2f
pdb|1H24|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH A 9 RESIDUE RECRUITMENT
Peptide From E2f
pdb|1H25|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From Retinoblastoma-Associated Protein
pdb|1H25|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From Retinoblastoma-Associated Protein
pdb|1H26|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P53
pdb|1H26|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P53
pdb|1H27|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P27
pdb|1H27|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P27
pdb|1H28|A Chain A, Cdk2/cyclin A In Complex With An 11-residue Recruitment
Peptide From P107
pdb|1H28|C Chain C, Cdk2/cyclin A In Complex With An 11-residue Recruitment
Peptide From P107
pdb|2WMA|A Chain A, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
pdb|2WMA|C Chain C, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
pdb|2WMB|A Chain A, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
pdb|2WMB|C Chain C, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
Length = 303
Score = 30.4 bits (67), Expect = 0.28, Method: Compositional matrix adjust.
Identities = 12/33 (36%), Positives = 22/33 (66%)
Query: 71 DDLVKICDLGRGAYGIVEKMRHVATGTMMAVKE 103
++ K+ +G G YG+V K R+ TG ++A+K+
Sbjct: 7 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKK 39
>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Nu6102
pdb|4EOK|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Nu6102
pdb|4EOL|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Ro3306
pdb|4EOL|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Ro3306
Length = 300
Score = 30.4 bits (67), Expect = 0.29, Method: Compositional matrix adjust.
Identities = 12/33 (36%), Positives = 22/33 (66%)
Query: 71 DDLVKICDLGRGAYGIVEKMRHVATGTMMAVKE 103
++ K+ +G G YG+V K R+ TG ++A+K+
Sbjct: 5 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKK 37
>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide,
Compound (S)-8b
pdb|3IG7|A Chain A, Novel Cdk-5 Inhibitors - Crystal Structure Of Inhibitor
Efp With Cdk-2
pdb|3IGG|A Chain A, Novel Cdk-5 Inhibitors - Crystal Structure Of Inhibitor
Efq With Cdk-2
pdb|1B38|A Chain A, Human Cyclin-Dependent Kinase 2
pdb|1B39|A Chain A, Human Cyclin-Dependent Kinase 2 Phosphorylated On Thr 160
pdb|1E1V|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor Nu2058
pdb|1E1X|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor Nu6027
pdb|1H00|A Chain A, Cdk2 In Complex With A Disubstituted 4, 6-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|1H07|A Chain A, Cdk2 In Complex With A Disubstituted 4, 6-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|1H08|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|2R3R|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|4ACM|A Chain A, Cdk2 In Complex With
3-Amino-6-(4-{[2-(Dimethylamino)ethyl]
Sulfamoyl}-Phenyl)-N-Pyridin-3-Ylpyrazine-2-Carboxamide
pdb|3SW4|A Chain A, Crystal Structure Of The Cdk2 In Complex With
Thiazolylpyrimidine Inhibitor
pdb|3SW7|A Chain A, Crystal Structure Of The Cdk2 In Complex With
Thiazolylpyrimidine Inhibitor
pdb|1OIQ|A Chain A, Imidazopyridines: A Potent And Selective Class Of
Cyclin-Dependent Kinase Inhibitors Identified Through
Structure-Based Hybridisation
pdb|1V1K|A Chain A, Cdk2 In Complex With A Disubstituted 4, 6-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|1URW|A Chain A, Cdk2 In Complex With An Imidazo[1,2-B]pyridazine
pdb|2VV9|A Chain A, Cdk2 In Complex With An Imidazole Piperazine
pdb|2W06|A Chain A, Structure Of Cdk2 In Complex With An Imidazolyl
Pyrimidine, Compound 5c
pdb|2R3G|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3H|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3F|A Chain A, Crystal Structure Of Cyclin-dependent Kinase 2 With
Inhibitor
Length = 299
Score = 30.4 bits (67), Expect = 0.29, Method: Compositional matrix adjust.
Identities = 12/33 (36%), Positives = 22/33 (66%)
Query: 71 DDLVKICDLGRGAYGIVEKMRHVATGTMMAVKE 103
++ K+ +G G YG+V K R+ TG ++A+K+
Sbjct: 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKK 35
>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed
With A
2-arylamino-4-cyclohexylmethyl-5-nitroso-6-
aminopyrimidine Inhibitor
pdb|1OGU|C Chain C, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed
With A
2-arylamino-4-cyclohexylmethyl-5-nitroso-6-
aminopyrimidine Inhibitor
pdb|1OI9|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OI9|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIU|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIU|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIY|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIY|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
Length = 302
Score = 30.4 bits (67), Expect = 0.29, Method: Compositional matrix adjust.
Identities = 12/33 (36%), Positives = 22/33 (66%)
Query: 71 DDLVKICDLGRGAYGIVEKMRHVATGTMMAVKE 103
++ K+ +G G YG+V K R+ TG ++A+K+
Sbjct: 6 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKK 38
>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 3
pdb|3BHT|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 3
pdb|3BHU|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 5
pdb|3BHU|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 5
pdb|3BHV|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Variolin B
pdb|3BHV|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Variolin B
pdb|3MY5|A Chain A, Cdk2CYCLINA IN COMPLEX WITH DRB
pdb|3MY5|C Chain C, Cdk2CYCLINA IN COMPLEX WITH DRB
pdb|3TNW|A Chain A, Structure Of Cdk2CYCLIN A IN COMPLEX WITH CAN508
pdb|3TNW|C Chain C, Structure Of Cdk2CYCLIN A IN COMPLEX WITH CAN508
pdb|4BCO|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
pdb|4BCO|C Chain C, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
Length = 300
Score = 30.4 bits (67), Expect = 0.29, Method: Compositional matrix adjust.
Identities = 12/33 (36%), Positives = 22/33 (66%)
Query: 71 DDLVKICDLGRGAYGIVEKMRHVATGTMMAVKE 103
++ K+ +G G YG+V K R+ TG ++A+K+
Sbjct: 4 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKK 36
>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex
pdb|1FIN|C Chain C, Cyclin A-Cyclin-Dependent Kinase 2 Complex
pdb|1CKP|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor Purvalanol B
pdb|1BUH|A Chain A, Crystal Structure Of The Human Cdk2 Kinase Complex With
Cell Cycle-Regulatory Protein Ckshs1
pdb|1DM2|A Chain A, Human Cyclin-Dependent Kinase 2 Complexed With The
Inhibitor Hymenialdisine
pdb|1DI8|A Chain A, The Structure Of Cyclin-Dependent Kinase 2 (Cdk2) In
Complex With
4-[3-Hydroxyanilino]-6,7-Dimethoxyquinazoline
pdb|1F5Q|A Chain A, Crystal Structure Of Murine Gamma Herpesvirus Cyclin
Complexed To Human Cyclin Dependent Kinase 2
pdb|1F5Q|C Chain C, Crystal Structure Of Murine Gamma Herpesvirus Cyclin
Complexed To Human Cyclin Dependent Kinase 2
pdb|1FVT|A Chain A, The Structure Of Cyclin-Dependent Kinase 2 (Cdk2) In
Complex With An Oxindole Inhibitor
pdb|1FVV|A Chain A, The Structure Of Cdk2CYCLIN A IN COMPLEX WITH AN OXINDOLE
Inhibitor
pdb|1FVV|C Chain C, The Structure Of Cdk2CYCLIN A IN COMPLEX WITH AN OXINDOLE
Inhibitor
pdb|1JSV|A Chain A, The Structure Of Cyclin-dependent Kinase 2 (cdk2) In
Complex With 4-[(6-amino-4-pyrimidinyl)
Amino]benzenesulfonamide
pdb|1G5S|A Chain A, Crystal Structure Of Human Cyclin Dependent Kinase 2
(Cdk2) In Complex With The Inhibitor H717
pdb|1JVP|P Chain P, Crystal Structure Of Human Cdk2 (Unphosphorylated) In
Complex With Pkf049-365
pdb|1GIH|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
pdb|1KE5|A Chain A, Cdk2 Complexed With N-methyl-4-{[(2-oxo-1,2-dihydro-3h-
Indol-3-ylidene)methyl]amino}benzenesulfonamide
pdb|1KE6|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With
N-Methyl-{4-
[2-(7-Oxo-6,7-Dihydro-8h-[1,3]thiazolo[5,4-E]indol-8-
Ylidene)hydrazino]phenyl}methanesulfonamide
pdb|1KE7|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With 3-{[(2,2-
Dioxido-1,
3-Dihydro-2-Benzothien-5-Yl)amino]methylene}-5-
(1,3-Oxazol-5-Yl)-1,3-Dihydro-2h-Indol-2-One
pdb|1KE8|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With
4-{[(2-Oxo-
1,2-Dihydro-3h-Indol-3-Ylidene)methyl]amino}-N-(1,3-
Thiazol-2-Yl)benzenesulfonamide
pdb|1KE9|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With 3-{[4-
({[amino(Imino)methyl]aminosulfonyl)anilino]methylene}-
2- Oxo-2,3-Dihydro-1h-Indole
pdb|1H0V|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With
The Inhibitor
2-Amino-6-[(R)-Pyrrolidino-5'-Yl]methoxypurine
pdb|1H0W|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With
The Inhibitor 2-Amino-6-[cyclohex-3-Enyl]methoxypurine
pdb|1P2A|A Chain A, The Structure Of Cyclin Dependent Kinase 2 (Ckd2) With A
Trisubstituted Naphthostyril Inhibitor
pdb|1OKV|A Chain A, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Ile-Phe-Nh2
pdb|1OKV|C Chain C, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Ile-Phe-Nh2
pdb|1OKW|A Chain A, Cyclin A Binding Groove Inhibitor
Ac-Arg-Arg-Leu-Asn-(M-Cl-Phe)-Nh2
pdb|1OKW|C Chain C, Cyclin A Binding Groove Inhibitor
Ac-Arg-Arg-Leu-Asn-(M-Cl-Phe)-Nh2
pdb|1OL1|A Chain A, Cyclin A Binding Groove Inhibitor
H-Cit-Cit-Leu-Ile-(P-F-Phe)-Nh2
pdb|1OL1|C Chain C, Cyclin A Binding Groove Inhibitor
H-Cit-Cit-Leu-Ile-(P-F-Phe)-Nh2
pdb|1OL2|A Chain A, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Asn-(P-F-Phe)-Nh2
pdb|1OL2|C Chain C, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Asn-(P-F-Phe)-Nh2
pdb|1PW2|A Chain A, Apo Structure Of Human Cyclin-Dependent Kinase 2
pdb|1PXI|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor 4-(2,5-dichloro-thiophen-3-yl)-pyrimidin-2-
Ylamine
pdb|1PXJ|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Ylamine
pdb|1PXK|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
N-[4-(2,4-dimethyl-thiazol-5-yl)pyrimidin-2-yl]-
N'-hydroxyiminoformamide
pdb|1PXL|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
[4-(2,4-dimethyl-thiazol-5-yl)-pyrimidin-2-yl]-
(4-trifluoromethyl-phenyl)-amine
pdb|1R78|A Chain A, Cdk2 Complex With A 4-alkynyl Oxindole Inhibitor
pdb|1PXM|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor 3-[4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-
Ylamino]-Phenol
pdb|1PXN|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor 4-[4-(4-Methyl-2-Methylamino-Thiazol-5-Yl)-
Pyrimidin-2-Ylamino]-Phenol
pdb|1PXO|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
[4-(2-Amino-4-Methyl-Thiazol-5-Yl)-Pyrimidin-2-
Yl]-(3-Nitro-Phenyl)-Amine
pdb|1PXP|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
N-[4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Yl]-
N',N'-Dimethyl-Benzene-1,4-Diamine
pdb|1VYZ|A Chain A, Structure Of Cdk2 Complexed With Pnu-181227
pdb|1PYE|A Chain A, Crystal Structure Of Cdk2 With Inhibitor
pdb|1URC|A Chain A, Cyclin A Binding Groove Inhibitor Ace-Arg-Lys-Leu- Phe-Gly
pdb|1URC|C Chain C, Cyclin A Binding Groove Inhibitor Ace-Arg-Lys-Leu- Phe-Gly
pdb|1W0X|C Chain C, Crystals Structure Of Human Cdk2 In Complex With The
Inhibitor Olomoucine.
pdb|1WCC|A Chain A, Screening For Fragment Binding By X-Ray Crystallography
pdb|1Y8Y|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Pyrazolo[1, 5-A]pyrimidine Inhibitor
pdb|1Y91|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Pyrazolo[1, 5-A]pyrimidine Inhibitor
pdb|2BHE|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With
The Inhibitor 5-Bromo-Indirubine
pdb|2BHH|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With
The Inhibitor 4-Hydroxypiperindinesulfonyl-Indirubine
pdb|2B52|A Chain A, Human Cyclin Dependent Kinase 2 (Cdk2) Complexed With Dph-
042562
pdb|2B53|A Chain A, Human Cyclin Dependent Kinase 2 (Cdk2) Complexed With Din-
234325
pdb|2B54|A Chain A, Human Cyclin Dependent Kinase 2 (Ckd2)complexed With Din-
232305
pdb|2B55|A Chain A, Human Cyclin Dependent Kinase 2 (Cdk2) Complexed With
Indenopyraxole Din-101312
pdb|2BTR|A Chain A, Structure Of Cdk2 Complexed With Pnu-198873
pdb|2BTS|A Chain A, Structure Of Cdk2 Complexed With Pnu-230032
pdb|2C68|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C69|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6I|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6K|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6L|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6M|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6O|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2EXM|A Chain A, Human Cdk2 In Complex With Isopentenyladenine
pdb|1YKR|A Chain A, Crystal Structure Of Cdk2 With An Aminoimidazo Pyridine
Inhibitor
pdb|2A0C|X Chain X, Human Cdk2 In Complex With Olomoucine Ii, A Novel 2,6,9-
Trisubstituted Purine Cyclin-Dependent Kinase Inhibitor
pdb|2C5N|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5N|C Chain C, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5O|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5O|C Chain C, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5V|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5V|C Chain C, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5X|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5X|C Chain C, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5Y|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2A4L|A Chain A, Human Cyclin-Dependent Kinase 2 In Complex With
Roscovitine
pdb|2FVD|A Chain A, Cyclin Dependent Kinase 2 (Cdk2) With Diaminopyrimidine
Inhibitor
pdb|2I40|A Chain A, Cdk2CYCLIN A COMPLEXED WITH A THIOPHENE CARBOXAMIDE
INHIBITOR
pdb|2I40|C Chain C, Cdk2CYCLIN A COMPLEXED WITH A THIOPHENE CARBOXAMIDE
INHIBITOR
pdb|2CLX|A Chain A, 4-Arylazo-3,5-Diamino-1h-Pyrazole Cdk Inhibitors: Sar
Study, Crystal Structure In Complex With Cdk2,
Selectivity, And Cellular Effects
pdb|2DUV|A Chain A, Structure Of Cdk2 With A 3-Hydroxychromones
pdb|2UUE|A Chain A, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2UUE|C Chain C, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2UZN|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZO|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2V0D|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|1AQ1|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor Staurosporine
pdb|1HCK|A Chain A, Human Cyclin-Dependent Kinase 2
pdb|1HCL|A Chain A, Human Cyclin-Dependent Kinase 2
pdb|2J9M|A Chain A, Crystal Structure Of Cdk2 In Complex With Macrocyclic
Aminopyrimidine
pdb|2V22|A Chain A, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2V22|C Chain C, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2VTA|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTH|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design
pdb|2VTI|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTJ|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTL|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTM|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTN|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTO|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTP|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTQ|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTR|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTS|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTT|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VU3|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2R64|A Chain A, Crystal Structure Of A 3-Aminoindazole Compound With Cdk2
pdb|2W05|A Chain A, Structure Of Cdk2 In Complex With An Imidazolyl
Pyrimidine, Compound 5b
pdb|3EID|A Chain A, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EID|C Chain C, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EJ1|A Chain A, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EJ1|C Chain C, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EOC|A Chain A, Cdk2/cyclina Complexed With A Imidazo Triazin-2-amine
pdb|3EOC|C Chain C, Cdk2/cyclina Complexed With A Imidazo Triazin-2-amine
pdb|2W1H|A Chain A, Fragment-Based Discovery Of The Pyrazol-4-Yl Urea
(At9283), A Multi-Targeted Kinase Inhibitor With Potent
Aurora Kinase Activity
pdb|3F5X|A Chain A, Cdk-2-Cyclin Complex With Indazole Inhibitor 9 Bound At
Its Active Site
pdb|3F5X|C Chain C, Cdk-2-Cyclin Complex With Indazole Inhibitor 9 Bound At
Its Active Site
pdb|3FZ1|A Chain A, Crystal Structure Of A Benzthiophene Inhibitor Bound To
Human Cyclin-Dependent Kinase-2 (Cdk-2)
pdb|2WEV|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WEV|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WFY|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WFY|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WHB|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WHB|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2X1N|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2X1N|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|3LFN|A Chain A, Crystal Structure Of Cdk2 With Sar57, An Aminoindazole
Type Inhibitor
pdb|3LFQ|A Chain A, Crystal Structure Of Cdk2 With Sar60, An Aminoindazole
Type Inhibitor
pdb|3LFS|A Chain A, Crystal Structure Of Cdk2 With Sar37, An Aminoindazole
Type Inhibitor
pdb|2XMY|A Chain A, Discovery And Characterisation Of
2-Anilino-4-(Thiazol-5-Yl) Pyrimidine Transcriptional
Cdk Inhibitors As Anticancer Agents
pdb|2XNB|A Chain A, Discovery And Characterisation Of
2-Anilino-4-(Thiazol-5-Yl) Pyrimidine Transcriptional
Cdk Inhibitors As Anticancer Agents
pdb|3LE6|A Chain A, The Structure Of Cyclin Dependent Kinase 2 (Ckd2) With A
Pyrazolobenzodiazepine Inhibitor
pdb|3NS9|A Chain A, Crystal Structure Of Cdk2 In Complex With Inhibitor Bs-194
pdb|3S2P|A Chain A, Crystal Structure Of Cdk2 With A 2-Aminopyrimidine
Compound
pdb|3UNJ|A Chain A, Cdk2 In Complex With Inhibitor Yl1-038-31
pdb|3UNK|A Chain A, Cdk2 In Complex With Inhibitor Yl5-083
pdb|3TI1|A Chain A, Cdk2 In Complex With Sunitinib
pdb|3TIY|A Chain A, Cdk2 In Complex With Nsc 35676
pdb|3TIZ|A Chain A, Cdk2 In Complex With Nsc 111848
Length = 298
Score = 30.4 bits (67), Expect = 0.29, Method: Compositional matrix adjust.
Identities = 12/33 (36%), Positives = 22/33 (66%)
Query: 71 DDLVKICDLGRGAYGIVEKMRHVATGTMMAVKE 103
++ K+ +G G YG+V K R+ TG ++A+K+
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKK 34
>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
pdb|2IW6|C Chain C, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
pdb|2IW9|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
pdb|2IW9|C Chain C, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
Length = 302
Score = 30.4 bits (67), Expect = 0.29, Method: Compositional matrix adjust.
Identities = 12/33 (36%), Positives = 22/33 (66%)
Query: 71 DDLVKICDLGRGAYGIVEKMRHVATGTMMAVKE 103
++ K+ +G G YG+V K R+ TG ++A+K+
Sbjct: 6 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKK 38
>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
pdb|4EOI|C Chain C, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
Length = 299
Score = 30.4 bits (67), Expect = 0.29, Method: Compositional matrix adjust.
Identities = 12/33 (36%), Positives = 22/33 (66%)
Query: 71 DDLVKICDLGRGAYGIVEKMRHVATGTMMAVKE 103
++ K+ +G G YG+V K R+ TG ++A+K+
Sbjct: 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKK 35
>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v-
H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor
pdb|2IW8|C Chain C, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v-
H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor
Length = 302
Score = 30.4 bits (67), Expect = 0.29, Method: Compositional matrix adjust.
Identities = 12/33 (36%), Positives = 22/33 (66%)
Query: 71 DDLVKICDLGRGAYGIVEKMRHVATGTMMAVKE 103
++ K+ +G G YG+V K R+ TG ++A+K+
Sbjct: 6 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKK 38
>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With Atp
pdb|4EOO|C Chain C, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With Atp
Length = 299
Score = 30.0 bits (66), Expect = 0.30, Method: Compositional matrix adjust.
Identities = 12/33 (36%), Positives = 22/33 (66%)
Query: 71 DDLVKICDLGRGAYGIVEKMRHVATGTMMAVKE 103
++ K+ +G G YG+V K R+ TG ++A+K+
Sbjct: 4 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKK 36
>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
pdb|1GIJ|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
pdb|2DS1|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
Length = 298
Score = 30.0 bits (66), Expect = 0.30, Method: Compositional matrix adjust.
Identities = 12/33 (36%), Positives = 22/33 (66%)
Query: 71 DDLVKICDLGRGAYGIVEKMRHVATGTMMAVKE 103
++ K+ +G G YG+V K R+ TG ++A+K+
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKK 34
>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A
Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine
Length = 299
Score = 30.0 bits (66), Expect = 0.30, Method: Compositional matrix adjust.
Identities = 12/33 (36%), Positives = 22/33 (66%)
Query: 71 DDLVKICDLGRGAYGIVEKMRHVATGTMMAVKE 103
++ K+ +G G YG+V K R+ TG ++A+K+
Sbjct: 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKK 35
>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
pdb|3QHR|C Chain C, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
pdb|3QHW|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
pdb|3QHW|C Chain C, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
Length = 298
Score = 30.0 bits (66), Expect = 0.30, Method: Compositional matrix adjust.
Identities = 12/33 (36%), Positives = 22/33 (66%)
Query: 71 DDLVKICDLGRGAYGIVEKMRHVATGTMMAVKE 103
++ K+ +G G YG+V K R+ TG ++A+K+
Sbjct: 4 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKK 36
>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And
Nck-Interacting Kinase With Wee1chk1 Inhibitor
pdb|2X7F|B Chain B, Crystal Structure Of The Kinase Domain Of Human Traf2- And
Nck-Interacting Kinase With Wee1chk1 Inhibitor
pdb|2X7F|C Chain C, Crystal Structure Of The Kinase Domain Of Human Traf2- And
Nck-Interacting Kinase With Wee1chk1 Inhibitor
pdb|2X7F|D Chain D, Crystal Structure Of The Kinase Domain Of Human Traf2- And
Nck-Interacting Kinase With Wee1chk1 Inhibitor
pdb|2X7F|E Chain E, Crystal Structure Of The Kinase Domain Of Human Traf2- And
Nck-Interacting Kinase With Wee1chk1 Inhibitor
Length = 326
Score = 30.0 bits (66), Expect = 0.36, Method: Composition-based stats.
Identities = 13/24 (54%), Positives = 16/24 (66%)
Query: 79 LGRGAYGIVEKMRHVATGTMMAVK 102
+G G YG V K RHV TG + A+K
Sbjct: 32 VGNGTYGQVYKGRHVKTGQLAAIK 55
>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain
pdb|2F2U|B Chain B, Crystal Structure Of The Rho-Kinase Kinase Domain
pdb|2H9V|A Chain A, Structural Basis For Induced-Fit Binding Of Rho-Kinase To
The Inhibitor Y27632
Length = 402
Score = 29.3 bits (64), Expect = 0.52, Method: Composition-based stats.
Identities = 15/34 (44%), Positives = 24/34 (70%), Gaps = 2/34 (5%)
Query: 69 EADDLVKICDLGRGAYGIVEKMRHVATGTMMAVK 102
E D+VK+ +GRGA+G V+ +RH A+ + A+K
Sbjct: 75 EDYDVVKV--IGRGAFGEVQLVRHKASQKVYAMK 106
>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase
pdb|3COM|B Chain B, Crystal Structure Of Mst1 Kinase
Length = 314
Score = 28.9 bits (63), Expect = 0.69, Method: Compositional matrix adjust.
Identities = 12/25 (48%), Positives = 17/25 (68%)
Query: 79 LGRGAYGIVEKMRHVATGTMMAVKE 103
LG G+YG V K H TG ++A+K+
Sbjct: 37 LGEGSYGSVYKAIHKETGQIVAIKQ 61
>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb
pdb|3MIA|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Atp-Bound
Human P-Tefb
Length = 351
Score = 28.9 bits (63), Expect = 0.72, Method: Composition-based stats.
Identities = 14/38 (36%), Positives = 21/38 (55%)
Query: 66 FVVEADDLVKICDLGRGAYGIVEKMRHVATGTMMAVKE 103
F E K+ +G+G +G V K RH TG +A+K+
Sbjct: 12 FCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKK 49
>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1
pdb|3BLQ|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 IN COMPLEX WITH
ATP
pdb|3BLR|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 IN COMPLEX WITH
Flavopiridol
pdb|3MY1|A Chain A, Structure Of Cdk9CYCLINT1 IN COMPLEX WITH DRB
pdb|3LQ5|A Chain A, Structure Of Cdk9CYCLINT IN COMPLEX WITH S-Cr8
pdb|3TN8|A Chain A, Cdk9CYCLIN T IN COMPLEX WITH CAN508
pdb|3TNH|A Chain A, Cdk9CYCLIN T IN COMPLEX WITH CAN508
pdb|3TNI|A Chain A, Structure Of Cdk9CYCLIN T F241L
pdb|4BCH|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
pdb|4BCI|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
pdb|4BCJ|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
Length = 331
Score = 28.9 bits (63), Expect = 0.72, Method: Composition-based stats.
Identities = 14/38 (36%), Positives = 21/38 (55%)
Query: 66 FVVEADDLVKICDLGRGAYGIVEKMRHVATGTMMAVKE 103
F E K+ +G+G +G V K RH TG +A+K+
Sbjct: 13 FCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKK 50
>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
Length = 331
Score = 28.9 bits (63), Expect = 0.73, Method: Composition-based stats.
Identities = 14/38 (36%), Positives = 21/38 (55%)
Query: 66 FVVEADDLVKICDLGRGAYGIVEKMRHVATGTMMAVKE 103
F E K+ +G+G +G V K RH TG +A+K+
Sbjct: 13 FCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKK 50
>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And
Drb
pdb|4EC9|A Chain A, Crystal Structure Of Full-Length Cdk9 In Complex With
Cyclin T
Length = 373
Score = 28.9 bits (63), Expect = 0.73, Method: Composition-based stats.
Identities = 14/38 (36%), Positives = 21/38 (55%)
Query: 66 FVVEADDLVKICDLGRGAYGIVEKMRHVATGTMMAVKE 103
F E K+ +G+G +G V K RH TG +A+K+
Sbjct: 13 FCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKK 50
>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex
With An Mkk5 Binding Fragment
pdb|4IC7|D Chain D, Crystal Structure Of The Erk5 Kinase Domain In Complex
With An Mkk5 Binding Fragment
pdb|4IC8|A Chain A, Crystal Structure Of The Apo Erk5 Kinase Domain
pdb|4IC8|B Chain B, Crystal Structure Of The Apo Erk5 Kinase Domain
Length = 442
Score = 28.5 bits (62), Expect = 0.86, Method: Compositional matrix adjust.
Identities = 13/34 (38%), Positives = 19/34 (55%)
Query: 70 ADDLVKICDLGRGAYGIVEKMRHVATGTMMAVKE 103
D+ I +G GAYG+V R TG +A+K+
Sbjct: 54 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKK 87
>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3
Length = 353
Score = 28.5 bits (62), Expect = 0.86, Method: Composition-based stats.
Identities = 12/25 (48%), Positives = 17/25 (68%)
Query: 79 LGRGAYGIVEKMRHVATGTMMAVKE 103
LG GAYG+V H TG ++A+K+
Sbjct: 19 LGEGAYGVVCSATHKPTGEIVAIKK 43
>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7
pdb|2B9I|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Msg5
pdb|2B9J|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Far1
pdb|2F49|A Chain A, Crystal Structure Of Fus3 In Complex With A Ste5 Peptide
pdb|2F49|B Chain B, Crystal Structure Of Fus3 In Complex With A Ste5 Peptide
pdb|2FA2|A Chain A, Crystal Structure Of Fus3 Without A Peptide From Ste5
pdb|2FA2|B Chain B, Crystal Structure Of Fus3 Without A Peptide From Ste5
Length = 353
Score = 28.5 bits (62), Expect = 0.89, Method: Composition-based stats.
Identities = 12/25 (48%), Positives = 17/25 (68%)
Query: 79 LGRGAYGIVEKMRHVATGTMMAVKE 103
LG GAYG+V H TG ++A+K+
Sbjct: 19 LGEGAYGVVCSATHKPTGEIVAIKK 43
>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor
Length = 398
Score = 28.5 bits (62), Expect = 0.90, Method: Compositional matrix adjust.
Identities = 13/34 (38%), Positives = 19/34 (55%)
Query: 70 ADDLVKICDLGRGAYGIVEKMRHVATGTMMAVKE 103
D+ I +G GAYG+V R TG +A+K+
Sbjct: 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKK 86
>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182
Length = 353
Score = 28.5 bits (62), Expect = 0.91, Method: Composition-based stats.
Identities = 12/25 (48%), Positives = 17/25 (68%)
Query: 79 LGRGAYGIVEKMRHVATGTMMAVKE 103
LG GAYG+V H TG ++A+K+
Sbjct: 19 LGEGAYGVVCSATHKPTGEIVAIKK 43
>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe
Complex Structure
pdb|2V55|C Chain C, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe
Complex Structure
Length = 406
Score = 28.5 bits (62), Expect = 0.99, Method: Composition-based stats.
Identities = 13/35 (37%), Positives = 24/35 (68%)
Query: 68 VEADDLVKICDLGRGAYGIVEKMRHVATGTMMAVK 102
++A+D + +GRGA+G V+ +RH +T + A+K
Sbjct: 71 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMK 105
>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil
pdb|2ESM|B Chain B, Crystal Structure Of Rock 1 Bound To Fasudil
pdb|2ETK|A Chain A, Crystal Structure Of Rock 1 Bound To Hydroxyfasudil
pdb|2ETK|B Chain B, Crystal Structure Of Rock 1 Bound To Hydroxyfasudil
pdb|2ETR|A Chain A, Crystal Structure Of Rock I Bound To Y-27632
pdb|2ETR|B Chain B, Crystal Structure Of Rock I Bound To Y-27632
pdb|3D9V|A Chain A, Crystal Structure Of Rock I Bound To H-1152p A Di-
Methylated Variant Of Fasudil
pdb|3D9V|B Chain B, Crystal Structure Of Rock I Bound To H-1152p A Di-
Methylated Variant Of Fasudil
pdb|3NCZ|A Chain A, X-Ray Co-Structure Of Rho-Associated Protein Kinase
(Rock1) With A Potent 2h-Isoquinolin-1-One Inhibitor
pdb|3NCZ|B Chain B, X-Ray Co-Structure Of Rho-Associated Protein Kinase
(Rock1) With A Potent 2h-Isoquinolin-1-One Inhibitor
pdb|3NCZ|C Chain C, X-Ray Co-Structure Of Rho-Associated Protein Kinase
(Rock1) With A Potent 2h-Isoquinolin-1-One Inhibitor
pdb|3NCZ|D Chain D, X-Ray Co-Structure Of Rho-Associated Protein Kinase
(Rock1) With A Potent 2h-Isoquinolin-1-One Inhibitor
pdb|3NDM|A Chain A, Crystal Structure Of Rho-Associated Protein Kinase (Rock1)
With A Potent Isoquinolone Derivative
pdb|3NDM|B Chain B, Crystal Structure Of Rho-Associated Protein Kinase (Rock1)
With A Potent Isoquinolone Derivative
pdb|3NDM|C Chain C, Crystal Structure Of Rho-Associated Protein Kinase (Rock1)
With A Potent Isoquinolone Derivative
pdb|3NDM|D Chain D, Crystal Structure Of Rho-Associated Protein Kinase (Rock1)
With A Potent Isoquinolone Derivative
Length = 415
Score = 28.5 bits (62), Expect = 1.0, Method: Composition-based stats.
Identities = 13/35 (37%), Positives = 24/35 (68%)
Query: 68 VEADDLVKICDLGRGAYGIVEKMRHVATGTMMAVK 102
++A+D + +GRGA+G V+ +RH +T + A+K
Sbjct: 71 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMK 105
>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex
With Indazole Derivative (Compound 18)
pdb|3V8S|B Chain B, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex
With Indazole Derivative (Compound 18)
pdb|3V8S|C Chain C, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex
With Indazole Derivative (Compound 18)
pdb|3V8S|D Chain D, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex
With Indazole Derivative (Compound 18)
pdb|3TV7|A Chain A, Human Rho-associated Protein Kinase 1 (rock 1) In Complex
With Rki1342
pdb|3TV7|B Chain B, Human Rho-associated Protein Kinase 1 (rock 1) In Complex
With Rki1342
pdb|3TV7|C Chain C, Human Rho-associated Protein Kinase 1 (rock 1) In Complex
With Rki1342
pdb|3TV7|D Chain D, Human Rho-associated Protein Kinase 1 (rock 1) In Complex
With Rki1342
pdb|3TWJ|A Chain A, Rho-Associated Protein Kinase 1 (Rock 1) In Complex With
Rki1447
pdb|3TWJ|B Chain B, Rho-Associated Protein Kinase 1 (Rock 1) In Complex With
Rki1447
pdb|3TWJ|C Chain C, Rho-Associated Protein Kinase 1 (Rock 1) In Complex With
Rki1447
pdb|3TWJ|D Chain D, Rho-Associated Protein Kinase 1 (Rock 1) In Complex With
Rki1447
Length = 410
Score = 28.5 bits (62), Expect = 1.0, Method: Composition-based stats.
Identities = 13/35 (37%), Positives = 24/35 (68%)
Query: 68 VEADDLVKICDLGRGAYGIVEKMRHVATGTMMAVK 102
++A+D + +GRGA+G V+ +RH +T + A+K
Sbjct: 66 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMK 100
>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum,
Cgd2_1960
pdb|3OZ6|B Chain B, Crystal Structure Of Mapk From Cryptosporidium Parvum,
Cgd2_1960
Length = 388
Score = 28.1 bits (61), Expect = 1.2, Method: Composition-based stats.
Identities = 18/37 (48%), Positives = 24/37 (64%), Gaps = 2/37 (5%)
Query: 67 VVEADDLVKICDLGRGAYGIVEKMRHVATGTMMAVKE 103
V+ +LVK LG+GAYGIV K TG ++AVK+
Sbjct: 7 VLRKYELVK--KLGKGAYGIVWKSIDRRTGEVVAVKK 41
>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of
Cyclin-Dependent Kinase Inhibitors Identified Through
Structure-Based Hybridisation
Length = 299
Score = 28.1 bits (61), Expect = 1.3, Method: Compositional matrix adjust.
Identities = 11/31 (35%), Positives = 20/31 (64%)
Query: 71 DDLVKICDLGRGAYGIVEKMRHVATGTMMAV 101
++ K+ +G G YG+V K R+ TG ++A+
Sbjct: 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVAL 33
>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino
Pyrimidine Cdk4 Inhibitor
Length = 298
Score = 28.1 bits (61), Expect = 1.3, Method: Compositional matrix adjust.
Identities = 11/31 (35%), Positives = 20/31 (64%)
Query: 71 DDLVKICDLGRGAYGIVEKMRHVATGTMMAV 101
++ K+ +G G YG+V K R+ TG ++A+
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVAL 32
>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain
pdb|4BBM|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain With
Bound Tcs 2312
pdb|4BBM|B Chain B, Crystal Structure Of The Human Cdkl2 Kinase Domain With
Bound Tcs 2312
Length = 331
Score = 27.7 bits (60), Expect = 1.5, Method: Composition-based stats.
Identities = 11/25 (44%), Positives = 19/25 (76%)
Query: 79 LGRGAYGIVEKMRHVATGTMMAVKE 103
+G G+YG+V K R+ TG ++A+K+
Sbjct: 33 VGEGSYGMVMKCRNKDTGRIVAIKK 57
>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In
Complex With Staurosporine
pdb|3S95|B Chain B, Crystal Structure Of The Human Limk1 Kinase Domain In
Complex With Staurosporine
Length = 310
Score = 27.3 bits (59), Expect = 2.0, Method: Compositional matrix adjust.
Identities = 13/37 (35%), Positives = 20/37 (54%)
Query: 67 VVEADDLVKICDLGRGAYGIVEKMRHVATGTMMAVKE 103
+ DL+ LG+G +G K+ H TG +M +KE
Sbjct: 6 IFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKE 42
>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase
(nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3)
Length = 350
Score = 27.3 bits (59), Expect = 2.0, Method: Composition-based stats.
Identities = 12/25 (48%), Positives = 17/25 (68%)
Query: 79 LGRGAYGIVEKMRHVATGTMMAVKE 103
LGRG++G V +M+ TG AVK+
Sbjct: 80 LGRGSFGEVHRMKDKQTGFQCAVKK 104
>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n
Inactivating Mutant In Apo Form
pdb|1ZXE|B Chain B, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n
Inactivating Mutant In Apo Form
pdb|1ZXE|C Chain C, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n
Inactivating Mutant In Apo Form
pdb|1ZXE|D Chain D, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n
Inactivating Mutant In Apo Form
pdb|1ZXE|E Chain E, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n
Inactivating Mutant In Apo Form
pdb|1ZXE|F Chain F, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n
Inactivating Mutant In Apo Form
Length = 303
Score = 27.3 bits (59), Expect = 2.1, Method: Compositional matrix adjust.
Identities = 13/34 (38%), Positives = 19/34 (55%)
Query: 70 ADDLVKICDLGRGAYGIVEKMRHVATGTMMAVKE 103
A D +I LG+GA+G V K R+ A+K+
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKK 38
>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik)
pdb|4G3D|B Chain B, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik)
pdb|4G3D|D Chain D, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik)
pdb|4G3D|E Chain E, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik)
Length = 371
Score = 27.3 bits (59), Expect = 2.4, Method: Compositional matrix adjust.
Identities = 12/25 (48%), Positives = 16/25 (64%)
Query: 79 LGRGAYGIVEKMRHVATGTMMAVKE 103
LGRG++G V +M TG AVK+
Sbjct: 101 LGRGSFGEVHRMEDKQTGFQCAVKK 125
>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild-
Type In Apo Form.
pdb|1ZYC|B Chain B, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild-
Type In Apo Form.
pdb|1ZYC|C Chain C, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild-
Type In Apo Form.
pdb|1ZYC|D Chain D, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild-
Type In Apo Form.
pdb|1ZYD|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild-
Type Complexed With Atp.
pdb|1ZYD|B Chain B, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild-
Type Complexed With Atp
Length = 303
Score = 26.9 bits (58), Expect = 2.8, Method: Compositional matrix adjust.
Identities = 13/34 (38%), Positives = 19/34 (55%)
Query: 70 ADDLVKICDLGRGAYGIVEKMRHVATGTMMAVKE 103
A D +I LG+GA+G V K R+ A+K+
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKK 38
>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native
pdb|3MFS|A Chain A, Cask-4m Cam Kinase Domain, Amppnp
pdb|3MFT|A Chain A, Cask-4m Cam Kinase Domain, Mn2+
pdb|3MFU|A Chain A, Cask-4m Cam Kinase Domain, Amppnp-Mn2+
Length = 351
Score = 26.9 bits (58), Expect = 2.8, Method: Compositional matrix adjust.
Identities = 11/33 (33%), Positives = 22/33 (66%), Gaps = 1/33 (3%)
Query: 71 DDLVKICD-LGRGAYGIVEKMRHVATGTMMAVK 102
+D+ ++C+ +G+GA+ +V + + TG AVK
Sbjct: 23 EDVYELCEVIGKGAFSVVRRCINRETGQQFAVK 55
>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g
Hyperactivating Mutant In Apo Form.
pdb|1ZY4|B Chain B, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g
Hyperactivating Mutant In Apo Form.
pdb|1ZY5|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g
Hyperactivating Mutant Complexed With Amppnp.
pdb|1ZY5|B Chain B, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g
Hyperactivating Mutant Complexed With Amppnp
Length = 303
Score = 26.9 bits (58), Expect = 2.9, Method: Compositional matrix adjust.
Identities = 13/34 (38%), Positives = 19/34 (55%)
Query: 70 ADDLVKICDLGRGAYGIVEKMRHVATGTMMAVKE 103
A D +I LG+GA+G V K R+ A+K+
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKK 38
>pdb|3KK9|A Chain A, Camkii Substrate Complex B
Length = 282
Score = 26.9 bits (58), Expect = 3.2, Method: Compositional matrix adjust.
Identities = 11/29 (37%), Positives = 17/29 (58%)
Query: 78 DLGRGAYGIVEKMRHVATGTMMAVKEKNS 106
+LG+GA+ +V + H TG A K N+
Sbjct: 12 ELGKGAFSVVRRCVHKTTGLEFAAKIINT 40
>pdb|3KK8|A Chain A, Camkii Substrate Complex A
Length = 284
Score = 26.9 bits (58), Expect = 3.2, Method: Compositional matrix adjust.
Identities = 11/29 (37%), Positives = 17/29 (58%)
Query: 78 DLGRGAYGIVEKMRHVATGTMMAVKEKNS 106
+LG+GA+ +V + H TG A K N+
Sbjct: 13 ELGKGAFSVVRRCVHKTTGLEFAAKIINT 41
>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex
pdb|3KL8|C Chain C, Camkiintide Inhibitor Complex
pdb|3KL8|E Chain E, Camkiintide Inhibitor Complex
pdb|3KL8|G Chain G, Camkiintide Inhibitor Complex
pdb|3KL8|I Chain I, Camkiintide Inhibitor Complex
Length = 269
Score = 26.6 bits (57), Expect = 3.4, Method: Compositional matrix adjust.
Identities = 11/29 (37%), Positives = 17/29 (58%)
Query: 78 DLGRGAYGIVEKMRHVATGTMMAVKEKNS 106
+LG+GA+ +V + H TG A K N+
Sbjct: 13 ELGKGAFSVVRRCVHKTTGLEFAAKIINT 41
>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound
pdb|2WQO|A Chain A, Structure Of Nek2 Bound To The Aminopyridine Cct241950
pdb|2XK3|A Chain A, Structure Of Nek2 Bound To Aminopyrazine Compound 35
pdb|2XK4|A Chain A, Structure Of Nek2 Bound To Aminopyrazine Compound 17
pdb|2XK6|A Chain A, Structure Of Nek2 Bound To Aminopyrazine Compound 36
pdb|2XK7|A Chain A, Structure Of Nek2 Bound To Aminopyrazine Compound 23
pdb|2XK8|A Chain A, Structure Of Nek2 Bound To Aminopyrazine Compound 15
pdb|2XKC|A Chain A, Structure Of Nek2 Bound To Aminopyrazine Compound 14
pdb|2XKD|A Chain A, Structure Of Nek2 Bound To Aminopyrazine Compound 12
pdb|2XKF|A Chain A, Structure Of Nek2 Bound To Aminopyrazine Compound 2
pdb|2XKE|A Chain A, Structure Of Nek2 Bound To Aminipyrazine Compound 5
pdb|2XNM|A Chain A, Structure Of Nek2 Bound To Cct
pdb|2XNN|A Chain A, Structure Of Nek2 Bound To Cct242430
pdb|2XNO|A Chain A, Structure Of Nek2 Bound To Cct243779
pdb|2XNP|A Chain A, Structure Of Nek2 Bound To Cct244858
pdb|4AFE|A Chain A, Nek2 Bound To Hybrid Compound 21
Length = 279
Score = 26.6 bits (57), Expect = 3.4, Method: Compositional matrix adjust.
Identities = 11/34 (32%), Positives = 20/34 (58%)
Query: 70 ADDLVKICDLGRGAYGIVEKMRHVATGTMMAVKE 103
A+D + +G G+YG +K+R + G ++ KE
Sbjct: 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKE 38
>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand
pdb|2W5B|A Chain A, Human Nek2 Kinase Atpgammas-bound
pdb|2W5H|A Chain A, Human Nek2 Kinase Apo
Length = 279
Score = 26.6 bits (57), Expect = 3.4, Method: Compositional matrix adjust.
Identities = 11/34 (32%), Positives = 20/34 (58%)
Query: 70 ADDLVKICDLGRGAYGIVEKMRHVATGTMMAVKE 103
A+D + +G G+YG +K+R + G ++ KE
Sbjct: 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKE 38
>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662
Length = 279
Score = 26.6 bits (57), Expect = 3.6, Method: Compositional matrix adjust.
Identities = 11/34 (32%), Positives = 20/34 (58%)
Query: 70 ADDLVKICDLGRGAYGIVEKMRHVATGTMMAVKE 103
A+D + +G G+YG +K+R + G ++ KE
Sbjct: 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKE 38
>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With
Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy)
Ethylamino)ethyl)amide
pdb|2C1B|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With
(4r,2s)-5'-(4-(4-Chlorobenzyloxy)pyrrolidin-2-
Ylmethanesulfonyl)isoquinoline
pdb|2VO7|A Chain A, Structure Of Pka Complexed With 4-(4-Chlorobenzyl)-1-(7h-
Pyrrolo(2,3-D)pyrimidin-4-Yl)piperidin-4-Ylamine
pdb|3AG9|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase
Inhibitor Arc-1012
pdb|3AG9|B Chain B, Complex Of Pka With The Bisubstrate Protein Kinase
Inhibitor Arc-1012
Length = 351
Score = 26.6 bits (57), Expect = 3.9, Method: Composition-based stats.
Identities = 12/32 (37%), Positives = 19/32 (59%)
Query: 71 DDLVKICDLGRGAYGIVEKMRHVATGTMMAVK 102
D +I LG G++G V ++H+ TG A+K
Sbjct: 42 DQFERIKTLGTGSFGRVMLVKHMETGNHYAMK 73
>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective
Inhibitors In Complex With Protein Kinase A And Mutants
Length = 350
Score = 26.6 bits (57), Expect = 3.9, Method: Composition-based stats.
Identities = 12/32 (37%), Positives = 19/32 (59%)
Query: 71 DDLVKICDLGRGAYGIVEKMRHVATGTMMAVK 102
D +I LG G++G V ++H+ TG A+K
Sbjct: 41 DQFERIKTLGTGSFGRVMLVKHMETGNHYAMK 72
>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective
Inhibitors In Complex With Protein Kinase A And Mutants
Length = 350
Score = 26.6 bits (57), Expect = 3.9, Method: Composition-based stats.
Identities = 12/32 (37%), Positives = 19/32 (59%)
Query: 71 DDLVKICDLGRGAYGIVEKMRHVATGTMMAVK 102
D +I LG G++G V ++H+ TG A+K
Sbjct: 41 DQFERIKTLGTGSFGRVMLVKHMETGNHYAMK 72
>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With
Azepane Derivative 8
pdb|1XH5|A Chain A, Crystal Structures Of Protein Kinase B Selective
Inhibitors In Complex With Protein Kinase A And Mutants
pdb|1XH6|A Chain A, Crystal Structures Of Protein Kinase B Selective
Inhibitors In Complex With Protein Kinase A And Mutants
pdb|1XH8|A Chain A, Crystal Structures Of Protein Kinase B Selective
Inhibitors In Complex With Protein Kinase A And Mutants
pdb|2GFC|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With
Pki-5-24
Length = 350
Score = 26.6 bits (57), Expect = 3.9, Method: Composition-based stats.
Identities = 12/32 (37%), Positives = 19/32 (59%)
Query: 71 DDLVKICDLGRGAYGIVEKMRHVATGTMMAVK 102
D +I LG G++G V ++H+ TG A+K
Sbjct: 41 DQFERIKTLGTGSFGRVMLVKHMETGNHYAMK 72
>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered
N- Terminal Helix
pdb|1XHA|A Chain A, Crystal Structures Of Protein Kinase B Selective
Inhibitors In Complex With Protein Kinase A And Mutants
Length = 350
Score = 26.6 bits (57), Expect = 3.9, Method: Composition-based stats.
Identities = 12/32 (37%), Positives = 19/32 (59%)
Query: 71 DDLVKICDLGRGAYGIVEKMRHVATGTMMAVK 102
D +I LG G++G V ++H+ TG A+K
Sbjct: 41 DQFERIKTLGTGSFGRVMLVKHMETGNHYAMK 72
>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein
Kinase A (Pka)
pdb|1SZM|B Chain B, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein
Kinase A (Pka)
Length = 350
Score = 26.6 bits (57), Expect = 3.9, Method: Composition-based stats.
Identities = 12/32 (37%), Positives = 19/32 (59%)
Query: 71 DDLVKICDLGRGAYGIVEKMRHVATGTMMAVK 102
D +I LG G++G V ++H+ TG A+K
Sbjct: 41 DQFERIKTLGTGSFGRVMLVKHMETGNHYAMK 72
>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In
Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077)
pdb|1XH4|A Chain A, Crystal Structures Of Protein Kinase B Selective
Inhibitors In Complex With Protein Kinase A And Mutants
pdb|3BWJ|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase
Inhibitor Lead Compound Arc-1034
pdb|3KKV|A Chain A, Structure Of Pka With A Protein Kinase B-Selective
Inhibitor
Length = 350
Score = 26.6 bits (57), Expect = 3.9, Method: Composition-based stats.
Identities = 12/32 (37%), Positives = 19/32 (59%)
Query: 71 DDLVKICDLGRGAYGIVEKMRHVATGTMMAVK 102
D +I LG G++G V ++H+ TG A+K
Sbjct: 41 DQFERIKTLGTGSFGRVMLVKHMETGNHYAMK 72
>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb
Length = 350
Score = 26.6 bits (57), Expect = 3.9, Method: Composition-based stats.
Identities = 12/32 (37%), Positives = 19/32 (59%)
Query: 71 DDLVKICDLGRGAYGIVEKMRHVATGTMMAVK 102
D +I LG G++G V ++H+ TG A+K
Sbjct: 41 DQFERIKTLGTGSFGRVMLVKHMETGNHYAMK 72
>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp
pdb|1Q62|A Chain A, Pka Double Mutant Model Of Pkb
Length = 350
Score = 26.6 bits (57), Expect = 3.9, Method: Composition-based stats.
Identities = 12/32 (37%), Positives = 19/32 (59%)
Query: 71 DDLVKICDLGRGAYGIVEKMRHVATGTMMAVK 102
D +I LG G++G V ++H+ TG A+K
Sbjct: 41 DQFERIKTLGTGSFGRVMLVKHMETGNHYAMK 72
>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With
Pki-5-24
pdb|3DNE|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With
Pki-5-24
Length = 350
Score = 26.6 bits (57), Expect = 3.9, Method: Composition-based stats.
Identities = 12/32 (37%), Positives = 19/32 (59%)
Query: 71 DDLVKICDLGRGAYGIVEKMRHVATGTMMAVK 102
D +I LG G++G V ++H+ TG A+K
Sbjct: 41 DQFERIKTLGTGSFGRVMLVKHMETGNHYAMK 72
>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4-
Chlorophenyl)-1-(7h-Pyrrolo(2,
3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine
Length = 351
Score = 26.6 bits (57), Expect = 3.9, Method: Composition-based stats.
Identities = 12/32 (37%), Positives = 19/32 (59%)
Query: 71 DDLVKICDLGRGAYGIVEKMRHVATGTMMAVK 102
D +I LG G++G V ++H+ TG A+K
Sbjct: 42 DQFERIKTLGTGSFGRVMLVKHMETGNHYAMK 73
>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h-
Purin-6-yl)-benzyl)-amine
pdb|2UVZ|A Chain A, Structure Of Pka-Pkb Chimera Complexed With
C-Phenyl-C-(4-( 9h-Purin-6-Yl)-Phenyl)-Methylamine
pdb|2UW0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With 6-(4-(4-(4-
Chloro-Phenyl)-Piperidin-4-Yl)-Phenyl)-9h-Purine
pdb|2UW3|A Chain A, Structure Of Pka-Pkb Chimera Complexed With 5-Methyl-4-
Phenyl-1h-Pyrazole
pdb|2UW5|A Chain A, Structure Of Pka-Pkb Chimera Complexed With (R)-2-(4-
Chloro-Phenyl)-2-(4-1h-Pyrazol-4-Yl)-Phenyl)-Ethylamine
pdb|2UW6|A Chain A, Structure Of Pka-Pkb Chimera Complexed With (S)-2-(4-
Chloro-Phenyl)-2-(4-1h-Pyrazol-4-Yl)-Phenyl)-Ethylamine
pdb|2UW8|A Chain A, Structure Of Pka-Pkb Chimera Complexed With 2-(4-Chloro-
Phenyl)-2-Phenyl-Ethylamine
pdb|2VNW|A Chain A, Structure Of Pka-Pkb Chimera Complexed With
(1-(9h-Purin-6- Yl)piperidin-4-Yl)methanamine
pdb|2VNY|A Chain A, Structure Of Pka-Pkb Chimera Complexed With
(1-(9h-Purin-6- Yl)piperidin-4-Yl)amine
pdb|2VO3|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4-
Chlorophenyl)-1-(7h-Pyrrolo(2,
3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine
pdb|2VO6|A Chain A, Structure Of Pka-Pkb Chimera Complexed With 4-(4-
Chlorobenzyl)-1-(7h-Pyrrolo(2,
3-D)pyrimidin-4-Yl)piperidin- 4-Ylamine
Length = 351
Score = 26.6 bits (57), Expect = 3.9, Method: Composition-based stats.
Identities = 12/32 (37%), Positives = 19/32 (59%)
Query: 71 DDLVKICDLGRGAYGIVEKMRHVATGTMMAVK 102
D +I LG G++G V ++H+ TG A+K
Sbjct: 42 DQFERIKTLGTGSFGRVMLVKHMETGNHYAMK 73
>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors
pdb|2UZU|E Chain E, Pka Structures Of Indazole-Pyridine Series Of Akt
Inhibitors
pdb|2UZV|A Chain A, Pka Structures Of Indazole-pyridine Series Of Akt
Inhibitors
pdb|2UZW|E Chain E, Pka Structures Of Indazole-Pyridine Series Of Akt
Inhibitors
Length = 336
Score = 26.6 bits (57), Expect = 3.9, Method: Composition-based stats.
Identities = 12/32 (37%), Positives = 19/32 (59%)
Query: 71 DDLVKICDLGRGAYGIVEKMRHVATGTMMAVK 102
D +I LG G++G V ++H+ TG A+K
Sbjct: 27 DQFERIKTLGTGSFGRVMLVKHMETGNHYAMK 58
>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With
Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy)
Ethylamino)ethyl) Amide
pdb|2JDV|A Chain A, Structure Of Pka-Pkb Chimera Complexed With A-443654
pdb|2UVX|A Chain A, Structure Of Pka-Pkb Chimera Complexed With 7-Azaindole
pdb|2UW4|A Chain A, Structure Of Pka-Pkb Chimera Complexed With
2-(4-(5-Methyl- 1h-Pyrazol-4-Yl)-Phenyl)-Ethylamine
pdb|2UW7|A Chain A, Structure Of Pka-Pkb Chimera Complexed With 4-(4-Chloro-
Phenyl)-4-(4-(1h-Pyrazol-4-Yl)-Phenyl)-Piperidine
pdb|4AXA|A Chain A, Structure Of Pka-pkb Chimera Complexed With
(1s)-2-amino-1-(
4-chlorophenyl)-1-(4-(1h-pyrazol-4-yl)phenyl)ethan-1-ol
Length = 351
Score = 26.6 bits (57), Expect = 3.9, Method: Composition-based stats.
Identities = 12/32 (37%), Positives = 19/32 (59%)
Query: 71 DDLVKICDLGRGAYGIVEKMRHVATGTMMAVK 102
D +I LG G++G V ++H+ TG A+K
Sbjct: 42 DQFERIKTLGTGSFGRVMLVKHMETGNHYAMK 73
>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With
A- 443654
Length = 351
Score = 26.6 bits (57), Expect = 3.9, Method: Composition-based stats.
Identities = 12/32 (37%), Positives = 19/32 (59%)
Query: 71 DDLVKICDLGRGAYGIVEKMRHVATGTMMAVK 102
D +I LG G++G V ++H+ TG A+K
Sbjct: 42 DQFERIKTLGTGSFGRVMLVKHMETGNHYAMK 73
>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase,
Alpha-Catalytic Subunit In Complex With H89 Protein
Kinase Inhibitor N-[2-
(4-Bromocinnamylamino)ethyl]-5-Isoquinoline
pdb|1YDR|E Chain E, Structure Of Camp-Dependent Protein Kinase,
Alpha-Catalytic Subunit In Complex With H7 Protein
Kinase Inhibitor 1-(5-
Isoquinolinesulfonyl)-2-Methylpiperazine
pdb|1YDS|E Chain E, Structure Of Camp-Dependent Protein Kinase,
Alpha-Catalytic Subunit In Complex With H8 Protein
Kinase Inhibitor [n-(2-Methylamino)ethyl]-5-
Isoquinolinesulfonamide
Length = 350
Score = 26.6 bits (57), Expect = 3.9, Method: Composition-based stats.
Identities = 12/32 (37%), Positives = 19/32 (59%)
Query: 71 DDLVKICDLGRGAYGIVEKMRHVATGTMMAVK 102
D +I LG G++G V ++H+ TG A+K
Sbjct: 41 DQFERIKTLGTGSFGRVMLVKHMETGNHYAMK 72
>pdb|2F7E|E Chain E, Pka Complexed With
(S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6-
Yl-Pyridin-3-Yloxymethyl-Etylamine
pdb|2F7X|E Chain E, Protein Kinase A Bound To
(s)-2-(1h-indol-3-yl)-1-[5-((e)-2-
Pyridin-4-yl-vinyl)-pyridin-3-yloxymethyl]-ethylamine
pdb|2F7Z|E Chain E, Protein Kinase A Bound To
(R)-1-(1h-Indol-3-Ylmethyl)-2-(2-
Pyridin-4-Yl-[1,7]naphtyridin-5-Yloxy)-Ehylamine
pdb|2OH0|E Chain E, Crystal Structure Of Protein Kinase A In Complex With
Pyridine-Pyrazolopyridine Based Inhibitors
pdb|2OJF|E Chain E, Crystal Structure Of Protein Kinase A In Complex With
Pyridine-Pyrazolopyridine Based Inhibitors
Length = 351
Score = 26.6 bits (57), Expect = 3.9, Method: Composition-based stats.
Identities = 12/32 (37%), Positives = 19/32 (59%)
Query: 71 DDLVKICDLGRGAYGIVEKMRHVATGTMMAVK 102
D +I LG G++G V ++H+ TG A+K
Sbjct: 42 DQFERIKTLGTGSFGRVMLVKHMETGNHYAMK 73
>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In
Complex With Staurosporine
pdb|1Q8T|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase
(Pka) In Complex With Rho-Kinase Inhibitor Y-27632
pdb|1Q8U|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In
Complex With Rho-Kinase Inhibitor H-1152p
pdb|1SVE|A Chain A, Crystal Structure Of Protein Kinase A In Complex With
Azepane Derivative 1
pdb|1SVG|A Chain A, Crystal Structure Of Protein Kinase A In Complex With
Azepane Derivative 4
pdb|1VEB|A Chain A, Crystal Structure Of Protein Kinase A In Complex With
Azepane Derivative 5
pdb|3E8C|A Chain A, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp- Competitive Inhibitors
pdb|3E8C|B Chain B, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp- Competitive Inhibitors
pdb|3E8C|C Chain C, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp- Competitive Inhibitors
pdb|3E8C|D Chain D, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp- Competitive Inhibitors
pdb|3E8C|E Chain E, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp- Competitive Inhibitors
pdb|3E8C|F Chain F, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp- Competitive Inhibitors
pdb|3E8E|A Chain A, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp-Competitive Inhibitors
pdb|3E8E|B Chain B, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp-Competitive Inhibitors
pdb|3E8E|E Chain E, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp-Competitive Inhibitors
pdb|3E8E|I Chain I, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp-Competitive Inhibitors
pdb|3E8E|L Chain L, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp-Competitive Inhibitors
pdb|3E8E|P Chain P, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp-Competitive Inhibitors
Length = 350
Score = 26.6 bits (57), Expect = 3.9, Method: Composition-based stats.
Identities = 12/32 (37%), Positives = 19/32 (59%)
Query: 71 DDLVKICDLGRGAYGIVEKMRHVATGTMMAVK 102
D +I LG G++G V ++H+ TG A+K
Sbjct: 41 DQFERIKTLGTGSFGRVMLVKHMETGNHYAMK 72
>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated
Protein Kinase And Immunoglobulin Domains
Length = 491
Score = 26.6 bits (57), Expect = 4.0, Method: Composition-based stats.
Identities = 11/25 (44%), Positives = 16/25 (64%)
Query: 78 DLGRGAYGIVEKMRHVATGTMMAVK 102
+LG GA+G+V ++ ATG A K
Sbjct: 58 ELGTGAFGVVHRVTERATGNNFAAK 82
>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans
(Fn31-Nl-Kin-Crd-Ig26)
pdb|3UTO|B Chain B, Twitchin Kinase Region From C.Elegans
(Fn31-Nl-Kin-Crd-Ig26)
Length = 573
Score = 26.6 bits (57), Expect = 4.0, Method: Composition-based stats.
Identities = 11/25 (44%), Positives = 16/25 (64%)
Query: 78 DLGRGAYGIVEKMRHVATGTMMAVK 102
+LG GA+G+V ++ ATG A K
Sbjct: 164 ELGTGAFGVVHRVTERATGNNFAAK 188
>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase
(nik)
pdb|4G3C|B Chain B, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase
(nik)
pdb|4G3E|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase
(nik) Bound To A 6-alkynylindoline (cmp1)
pdb|4G3E|B Chain B, Crystal Structure Of Murine Nf-kappab Inducing Kinase
(nik) Bound To A 6-alkynylindoline (cmp1)
Length = 352
Score = 26.6 bits (57), Expect = 4.2, Method: Compositional matrix adjust.
Identities = 11/25 (44%), Positives = 17/25 (68%)
Query: 79 LGRGAYGIVEKMRHVATGTMMAVKE 103
+GRG++G V +M+ TG AVK+
Sbjct: 82 VGRGSFGEVHRMKDKQTGFQCAVKK 106
>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of
CalciumCALMODULIN ACTIVATED KINASE II
pdb|2BDW|B Chain B, Crystal Structure Of The Auto-Inhibited Kinase Domain Of
CalciumCALMODULIN ACTIVATED KINASE II
Length = 362
Score = 26.2 bits (56), Expect = 4.5, Method: Compositional matrix adjust.
Identities = 10/25 (40%), Positives = 15/25 (60%)
Query: 78 DLGRGAYGIVEKMRHVATGTMMAVK 102
+LG+GA+ +V + H TG A K
Sbjct: 36 ELGKGAFSVVRRCVHKTTGLEFAAK 60
>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik)
pdb|4DN5|B Chain B, Crystal Structure Of Nf-kb-inducing Kinase (nik)
Length = 356
Score = 26.2 bits (56), Expect = 4.6, Method: Composition-based stats.
Identities = 12/25 (48%), Positives = 16/25 (64%)
Query: 79 LGRGAYGIVEKMRHVATGTMMAVKE 103
LGRG++G V +M TG AVK+
Sbjct: 82 LGRGSFGEVHRMEDKQTGFQCAVKK 106
>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase
Kinase 5
pdb|2CLQ|B Chain B, Structure Of Mitogen-Activated Protein Kinase Kinase
Kinase 5
Length = 295
Score = 26.2 bits (56), Expect = 4.7, Method: Compositional matrix adjust.
Identities = 11/25 (44%), Positives = 16/25 (64%)
Query: 79 LGRGAYGIVEKMRHVATGTMMAVKE 103
LG+G YGIV R ++ +A+KE
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKE 54
>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating
Kinase 1 (Ask1) With Imidazopyridine Inhibitor
pdb|3VW6|B Chain B, Crystal Structure Of Human Apoptosis Signal-Regulating
Kinase 1 (Ask1) With Imidazopyridine Inhibitor
Length = 269
Score = 26.2 bits (56), Expect = 5.1, Method: Compositional matrix adjust.
Identities = 11/25 (44%), Positives = 16/25 (64%)
Query: 79 LGRGAYGIVEKMRHVATGTMMAVKE 103
LG+G YGIV R ++ +A+KE
Sbjct: 16 LGKGTYGIVYAGRDLSNQVRIAIKE 40
>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase
(nik) Bound To A 2-(aminothiazoly)phenol (cmp2)
Length = 336
Score = 26.2 bits (56), Expect = 5.1, Method: Composition-based stats.
Identities = 11/25 (44%), Positives = 17/25 (68%)
Query: 79 LGRGAYGIVEKMRHVATGTMMAVKE 103
+GRG++G V +M+ TG AVK+
Sbjct: 66 VGRGSFGEVHRMKDKQTGFQCAVKK 90
>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And
Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1)
Length = 311
Score = 26.2 bits (56), Expect = 5.3, Method: Compositional matrix adjust.
Identities = 13/32 (40%), Positives = 18/32 (56%)
Query: 75 KICDLGRGAYGIVEKMRHVATGTMMAVKEKNS 106
++ LG G+YG V K+R G + AVK S
Sbjct: 61 RLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMS 92
>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp
pdb|3GU5|A Chain A, Crystal Structure Of Dapkq23v-Amppnp-Mg2+
pdb|3GU6|A Chain A, Crystal Structure Of Dapkq23v-Adp
pdb|3GU7|A Chain A, Crystal Structure Of Dapkq23v-Adp-Mg2+
Length = 295
Score = 25.8 bits (55), Expect = 6.2, Method: Compositional matrix adjust.
Identities = 10/25 (40%), Positives = 15/25 (60%)
Query: 78 DLGRGAYGIVEKMRHVATGTMMAVK 102
+LG G + +V+K R +TG A K
Sbjct: 18 ELGSGVFAVVKKCREKSTGLQYAAK 42
>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of
Camp-Dependent Protein Kinase And An Inhibitor Peptide
Displays An Open Conformation
Length = 350
Score = 25.8 bits (55), Expect = 6.9, Method: Composition-based stats.
Identities = 12/32 (37%), Positives = 18/32 (56%)
Query: 71 DDLVKICDLGRGAYGIVEKMRHVATGTMMAVK 102
D +I LG G++G V ++H TG A+K
Sbjct: 41 DQFERIKTLGTGSFGRVMLVKHKETGNHFAMK 72
>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit
(E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein
Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24)
Isoelectric Variant Ca) And Mn2+ Adenylyl
Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c
pdb|1CDK|B Chain B, Camp-Dependent Protein Kinase Catalytic Subunit
(E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein
Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24)
Isoelectric Variant Ca) And Mn2+ Adenylyl
Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c
Length = 350
Score = 25.8 bits (55), Expect = 6.9, Method: Composition-based stats.
Identities = 12/32 (37%), Positives = 18/32 (56%)
Query: 71 DDLVKICDLGRGAYGIVEKMRHVATGTMMAVK 102
D +I LG G++G V ++H TG A+K
Sbjct: 41 DQFERIKTLGTGSFGRVMLVKHKETGNHFAMK 72
>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit
Of Camp- Dependent Protein Kinase Reveal Open And Closed
Conformations
Length = 350
Score = 25.8 bits (55), Expect = 6.9, Method: Composition-based stats.
Identities = 12/32 (37%), Positives = 18/32 (56%)
Query: 71 DDLVKICDLGRGAYGIVEKMRHVATGTMMAVK 102
D +I LG G++G V ++H TG A+K
Sbjct: 41 DQFERIKTLGTGSFGRVMLVKHKETGNHFAMK 72
>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With
Y- 27632
Length = 350
Score = 25.4 bits (54), Expect = 7.7, Method: Composition-based stats.
Identities = 11/32 (34%), Positives = 19/32 (59%)
Query: 71 DDLVKICDLGRGAYGIVEKMRHVATGTMMAVK 102
D +I +G G++G V ++H+ TG A+K
Sbjct: 41 DQFERIKTIGTGSFGRVMLVKHMETGNHYAMK 72
>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632
pdb|2GNL|A Chain A, Pka Threefold Mutant Model Of Rho-Kinase With Inhibitor H-
1152p
Length = 350
Score = 25.4 bits (54), Expect = 7.7, Method: Composition-based stats.
Identities = 11/32 (34%), Positives = 19/32 (59%)
Query: 71 DDLVKICDLGRGAYGIVEKMRHVATGTMMAVK 102
D +I +G G++G V ++H+ TG A+K
Sbjct: 41 DQFERIKTIGTGSFGRVMLVKHMETGNHYAMK 72
>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase
pdb|2GNH|A Chain A, Pka Five Fold Mutant Model Of Rho-Kinase With H1152p
pdb|2GNI|A Chain A, Pka Fivefold Mutant Model Of Rho-Kinase With Inhibitor
Fasudil (Ha1077)
Length = 350
Score = 25.4 bits (54), Expect = 7.7, Method: Composition-based stats.
Identities = 11/32 (34%), Positives = 19/32 (59%)
Query: 71 DDLVKICDLGRGAYGIVEKMRHVATGTMMAVK 102
D +I +G G++G V ++H+ TG A+K
Sbjct: 41 DQFERIKTIGTGSFGRVMLVKHMETGNHYAMK 72
>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma
Viral Oncogene Homologue (V-Fes) In Complex With
Staurosporine And A Consensus Peptide
Length = 377
Score = 25.4 bits (54), Expect = 9.1, Method: Composition-based stats.
Identities = 15/37 (40%), Positives = 22/37 (59%)
Query: 66 FVVEADDLVKICDLGRGAYGIVEKMRHVATGTMMAVK 102
+V+ +DLV +GRG +G V R A T++AVK
Sbjct: 109 WVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVK 145
>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene
Homologue (V- Fes)
pdb|3CBL|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene
Homologue (v- Fes) In Complex With Staurosporine And A
Consensus Peptide
pdb|4E93|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene
Homologue (V- Fes)in Complex With Tae684
Length = 377
Score = 25.4 bits (54), Expect = 9.2, Method: Composition-based stats.
Identities = 15/37 (40%), Positives = 22/37 (59%)
Query: 66 FVVEADDLVKICDLGRGAYGIVEKMRHVATGTMMAVK 102
+V+ +DLV +GRG +G V R A T++AVK
Sbjct: 109 WVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVK 145
>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform
Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2
pdb|4AE9|B Chain B, Structure And Function Of The Human Sperm-specific Isoform
Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2
Length = 343
Score = 25.4 bits (54), Expect = 9.3, Method: Composition-based stats.
Identities = 12/32 (37%), Positives = 18/32 (56%)
Query: 71 DDLVKICDLGRGAYGIVEKMRHVATGTMMAVK 102
D +I LG G++G V ++H TG A+K
Sbjct: 34 DQFERIKTLGTGSFGRVMLVKHKETGNHYAMK 65
>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform
Of Protein Kinase A (pka) Catalytic Subunit Calpha 2
pdb|4AE6|B Chain B, Structure And Function Of The Human Sperm-specific Isoform
Of Protein Kinase A (pka) Catalytic Subunit Calpha 2
Length = 343
Score = 25.4 bits (54), Expect = 9.3, Method: Composition-based stats.
Identities = 12/32 (37%), Positives = 18/32 (56%)
Query: 71 DDLVKICDLGRGAYGIVEKMRHVATGTMMAVK 102
D +I LG G++G V ++H TG A+K
Sbjct: 34 DQFERIKTLGTGSFGRVMLVKHKETGNHYAMK 65
>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol
Length = 351
Score = 25.4 bits (54), Expect = 9.3, Method: Composition-based stats.
Identities = 12/32 (37%), Positives = 18/32 (56%)
Query: 71 DDLVKICDLGRGAYGIVEKMRHVATGTMMAVK 102
D +I LG G++G V ++H TG A+K
Sbjct: 42 DQFERIKTLGTGSFGRVMLVKHKETGNHYAMK 73
>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a,
L173m, Q181k) With Compound 18
pdb|3L9M|B Chain B, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a,
L173m, Q181k) With Compound 18
pdb|3L9N|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a,
L173m, Q181k) With Compound 27
Length = 351
Score = 25.4 bits (54), Expect = 9.3, Method: Composition-based stats.
Identities = 12/32 (37%), Positives = 18/32 (56%)
Query: 71 DDLVKICDLGRGAYGIVEKMRHVATGTMMAVK 102
D +I LG G++G V ++H TG A+K
Sbjct: 42 DQFERIKTLGTGSFGRVMLVKHKETGNHYAMK 73
>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase
Inhibitor Arc-670
pdb|3L9L|A Chain A, Crystal Structure Of Pka With Compound 36
pdb|3L9L|B Chain B, Crystal Structure Of Pka With Compound 36
pdb|3OOG|A Chain A, Human Camp-Dependent Protein Kinase In Complex With A
Small Fragment
pdb|3OVV|A Chain A, Human Camp-Dependent Protein Kinase In Complex With An
Inhibitor
pdb|3OWP|A Chain A, Human Camp-Dependent Protein Kinase In Complex With An
Inhibitor
pdb|3OXT|A Chain A, Human Camp-Dependent Protein Kinase In Complex With An
Inhibitor
pdb|3P0M|A Chain A, Human Camp-Dependent Protein Kinase In Complex With An
Inhibitor
pdb|3POO|A Chain A, Human Camp-Dependent Protein Kinase In Complex With An
Inhibitor
Length = 351
Score = 25.4 bits (54), Expect = 9.3, Method: Composition-based stats.
Identities = 12/32 (37%), Positives = 18/32 (56%)
Query: 71 DDLVKICDLGRGAYGIVEKMRHVATGTMMAVK 102
D +I LG G++G V ++H TG A+K
Sbjct: 42 DQFERIKTLGTGSFGRVMLVKHKETGNHYAMK 73
>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase
Inhibitor Arc-1039
pdb|3AGL|B Chain B, Complex Of Pka With The Bisubstrate Protein Kinase
Inhibitor Arc-1039
pdb|3VQH|A Chain A, Bromine Sad Partially Resolves Multiple Binding Modes For
Pka Inhibitor H-89
Length = 351
Score = 25.4 bits (54), Expect = 9.3, Method: Composition-based stats.
Identities = 12/32 (37%), Positives = 18/32 (56%)
Query: 71 DDLVKICDLGRGAYGIVEKMRHVATGTMMAVK 102
D +I LG G++G V ++H TG A+K
Sbjct: 42 DQFERIKTLGTGSFGRVMLVKHKETGNHYAMK 73
>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor
Complex
pdb|3MVJ|B Chain B, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor
Complex
pdb|3MVJ|E Chain E, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor
Complex
Length = 371
Score = 25.4 bits (54), Expect = 9.3, Method: Composition-based stats.
Identities = 12/32 (37%), Positives = 18/32 (56%)
Query: 71 DDLVKICDLGRGAYGIVEKMRHVATGTMMAVK 102
D +I LG G++G V ++H TG A+K
Sbjct: 62 DQFERIKTLGTGSFGRVMLVKHKETGNHYAMK 93
>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
pdb|2HAK|B Chain B, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
pdb|2HAK|C Chain C, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
pdb|2HAK|D Chain D, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
pdb|2HAK|E Chain E, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
pdb|2HAK|F Chain F, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
pdb|2HAK|G Chain G, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
pdb|2HAK|H Chain H, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
Length = 328
Score = 25.4 bits (54), Expect = 9.3, Method: Composition-based stats.
Identities = 11/24 (45%), Positives = 16/24 (66%)
Query: 79 LGRGAYGIVEKMRHVATGTMMAVK 102
+G+G + V+ RHV TG +AVK
Sbjct: 23 IGKGNFAKVKLARHVLTGREVAVK 46
Database: pdbaa
Posted date: Mar 3, 2013 10:34 PM
Number of letters in database: 14,973,337
Number of sequences in database: 62,578
Lambda K H
0.315 0.132 0.358
Lambda K H
0.267 0.0410 0.140
Matrix: BLOSUM62
Gap Penalties: Existence: 11, Extension: 1
Number of Hits to DB: 2,427,695
Number of Sequences: 62578
Number of extensions: 65921
Number of successful extensions: 552
Number of sequences better than 100.0: 131
Number of HSP's better than 100.0 without gapping: 126
Number of HSP's successfully gapped in prelim test: 5
Number of HSP's that attempted gapping in prelim test: 426
Number of HSP's gapped (non-prelim): 131
length of query: 106
length of database: 14,973,337
effective HSP length: 71
effective length of query: 35
effective length of database: 10,530,299
effective search space: 368560465
effective search space used: 368560465
T: 11
A: 40
X1: 16 ( 7.3 bits)
X2: 38 (14.6 bits)
X3: 64 (24.7 bits)
S1: 41 (21.6 bits)
S2: 45 (21.9 bits)